Research Portfolio

Search by: Title Institution Investigator Cycle Award Type Research Priority

Funding Opportunities

Call for Applications

Join our Mailing List

Join our mailing list to be notified of new funding opportunities. Your Email To receive information about funding opportunities, events, and program updates.

Research Project Awards

A novel imaging technology for the early detection of Oral C	2015 (Cycle 24)	$421,842
University of California, Los Angeles	Early Diagnosis/Pathogenesis

Cytotoxicity and Stress Induction by Thirdhand Smoke	2015 (Cycle 24)	$444,081
University of California, Riverside	Environmental Exposure/Toxicology

Role of Glutamate/ACh co-release in nicotine addiction	2015 (Cycle 24)	$421,875
University of California, San Diego	Disparities /Prevention/ Cessation/ Nicotine Dependence

Smoking and Embryonal Tumor Study	2015 (Cycle 24)	$450,835
University of California, Los Angeles	Regulatory Science/New Products

Population studies of new tobacco products and cigarettes	2015 (Cycle 24)	$406,492
University of California, San Diego	Regulatory Science/New Products

DUAL USE OF MARIJUANA AND TOBACCO: SOCIAL MEDIA AND YOUTH	2015 (Cycle 24)	$566,562
HBSA, Inc.	Disparities /Prevention/ Cessation/ Nicotine Dependence

The role of PACAP/PAC1 receptor system in nicotine addiction	2015 (Cycle 24)	$490,832
Western University of Health Sciences	Disparities /Prevention/ Cessation/ Nicotine Dependence

Using technology to help low-income and Latino smokers quit	2015 (Cycle 24)	$488,628
Palo Alto University, Inc.	Disparities /Prevention/ Cessation/ Nicotine Dependence

Metabolic consequences of tobacco toxicants	2015 (Cycle 24)	$421,875
University of California, San Diego	Early Diagnosis/Pathogenesis

Genotoxicity and Novel Biomarkers of Thirdhand Smoke	2015 (Cycle 24)	$644,618
Lawrence Berkeley National Laboratory	Environmental Exposure/Toxicology

Air pollution, tobacco smoke, & asthma in minority children	2015 (Cycle 24)	$412,913
University of California, San Francisco	Environmental Exposure/Toxicology

Electronic Nicotine Delivery Systems and California Youth	2015 (Cycle 24)	$545,532
HBSA, Inc.	Regulatory Science/New Products

Prevention of relapse in nicotine dependence: role of mGluR7	2015 (Cycle 24)	$421,875
University of California, San Diego	Disparities /Prevention/ Cessation/ Nicotine Dependence

Tobacco Treatment for Employable Californians	2015 (Cycle 24)	$573,934
Stanford University	Disparities /Prevention/ Cessation/ Nicotine Dependence

The Role of CSN6 in Cardiac Muscle and Sudden Cardiac Death	2015 (Cycle 24)	$421,875
University of California, San Diego	Early Diagnosis/Pathogenesis

Controlled Thirdhand Smoke Exposure Core	2015 (Cycle 24)	$304,957
University of California, San Francisco	Environmental Exposure/Toxicology

The Cost of Smoking for CA's Racial/Ethnic Communities	2015 (Cycle 24)	$165,972
University of California, San Francisco	Disparities /Prevention/ Cessation/ Nicotine Dependence

Airway inflammation in the evolution of airway fibrosis	2015 (Cycle 24)	$421,284
University of California, San Francisco	Early Diagnosis/Pathogenesis

Assessing Toxicity of Tobacco Product Waste to Humans	2014 (Cycle 23)	$527,249
San Diego State University Research Foundation	Environmental Exposure/Toxicology

Biological Impact of E-Cigarettes on Lung Carcinogenesis	2014 (Cycle 23)	$444,879
University of California, Los Angeles	Regulatory Science/New Products

Tobacco Use Disparities in California's Priority Populations	2014 (Cycle 23)	$326,069
University of California, San Diego	Disparities /Prevention/ Cessation/ Nicotine Dependence

Perinatal Tobacco Exposure Epigenetics & Transgenerational	2014 (Cycle 23)	$445,312
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Environmental Exposure/Toxicology

Tobacco Use Disparities in Californias Priority Populations	2014 (Cycle 23)	$127,634
Claremont Graduate University	Disparities /Prevention/ Cessation/ Nicotine Dependence

Early Diagnosis/Pathogenesis of Tobacco-Related Lung Disease	2014 (Cycle 23)	$675,093
Scripps Research Institute	Early Diagnosis/Pathogenesis

ENDS on campus: Changes in policy and retail environments	2014 (Cycle 23)	$527,296
Stanford University	Industry Influence/Policy

Genomic Signatures of CVD in Twins Discordant for Smoking	2014 (Cycle 23)	$461,488
University of California, San Diego	Early Diagnosis/Pathogenesis

Toward Smoke-Free Casinos: The Win-River Experience	2013 (Cycle 22)	$269,209
San Diego State University Research Foundation	Environmental Exposure/Toxicology

Early Detection of Stroke and Cardiovascular Disease Risk	2013 (Cycle 22)	$586,770
Children's Hospital Oakland Research Institute	Early Diagnosis/Pathogenesis

Joint roles of ceramide, EGFR/Src in lung injury and cancer	2013 (Cycle 22)	$467,498
University of California, Davis	Early Diagnosis/Pathogenesis

Health and economic toll of tobacco on CA's LGBT community	2013 (Cycle 22)	$375,845
University of California, San Francisco	Disparities /Prevention/ Cessation/ Nicotine Dependence

A Family-Based Approach To Reduce Smoking in Vietnamese Men	2013 (Cycle 22)	$508,987
University of California, San Francisco	Disparities /Prevention/ Cessation/ Nicotine Dependence

Developmental Nicotine Exposure and Addiction	2013 (Cycle 22)	$348,348
University of California, Los Angeles	Disparities /Prevention/ Cessation/ Nicotine Dependence

Developmental Nicotine Exposure and Addiction	2013 (Cycle 22)	$102,816
University of California, Irvine	Disparities /Prevention/ Cessation/ Nicotine Dependence

Ultra Low Dose, Effective CT for Lung Cancer Screening	2013 (Cycle 22)	$420,238
University of California, Los Angeles	Early Diagnosis/Pathogenesis

Social media messaging and public health campaigns: Prop 29	2013 (Cycle 22)	$290,315
University of California, San Diego	Industry Influence/Policy

Economic impact of tobacco taxes on African Americans	2013 (Cycle 22)	$467,178
University of California, San Francisco	Disparities /Prevention/ Cessation/ Nicotine Dependence

Shared Genetics of COPD and Lung Cancer	2013 (Cycle 22)	$549,561
Kaiser Foundation Research Institute	Early Diagnosis/Pathogenesis

Metals and nanoparticles in electronic cigarette aerosol	2013 (Cycle 22)	$264,176
University of California, Riverside	Regulatory Science/New Products

Effects of THS toxins on mechanical and drug-induced injury	2013 (Cycle 22)	$450,896
University of California, Riverside	Environmental Exposure/Toxicology

GIS tools for surveillance and regulation of flavored OTPs	2013 (Cycle 22)	$553,520
Stanford University	Industry Influence/Policy

African American Perceptions of Tobacco Denormalization Approaches	2013 (Cycle 22)	$600,361
HBSA, Inc.	Disparities /Prevention/ Cessation/ Nicotine Dependence

Clinical Validation of Salivary Oral Cancer Biomarkers	2012 (Cycle 21)	$521,831
University of California, Los Angeles	Early Diagnosis/Pathogenesis

Fotonovela to prevent SHS exposure in multiunit housing	2012 (Cycle 21)	$785,104
University of Southern California	Disparities /Prevention/ Cessation/ Nicotine Dependence

Third hand smoke and hypersensitivity	2012 (Cycle 21)	$668,192
Stanford University	Environmental Exposure/Toxicology

Barriers to Blue-Collar HMO Smoking Cessation Participation	2012 (Cycle 21)	$710,025
HBSA, Inc.	Disparities /Prevention/ Cessation/ Nicotine Dependence

Tobacco control policy and population-level harm reduction	2012 (Cycle 21)	$459,900
University of California, San Diego	Regulatory Science/New Products

Certifying Smoke-Free Used Cars	2012 (Cycle 21)	$686,734
San Diego State University Research Foundation	Industry Influence/Policy

Preventing and Reducing Tobacco Use Among Homeless Youth	2012 (Cycle 21)	$879,484
RAND Corporation	Disparities /Prevention/ Cessation/ Nicotine Dependence

Non-Nicotine Tobacco Constituents in Reward: Age Effects	2012 (Cycle 21)	$275,155
University of California, Irvine	Disparities /Prevention/ Cessation/ Nicotine Dependence

Suppression of lung adenocarcinoma by miR-34 microRNAs	2012 (Cycle 21)	$459,900
University of California, Berkeley	Early Diagnosis/Pathogenesis

African American Smoking and Quitting in California	2012 (Cycle 21)	$382,402
Claremont Graduate University	Disparities /Prevention/ Cessation/ Nicotine Dependence

A Novel Approach to Prevent in Utero Nicotine Lung Injury	2008 (Cycle 17)	$564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center	General Biomedical Science

Preserving At Risk Tobacco Control Policy Resources	2008 (Cycle 17)	$392,644
University of California, San Francisco	Public Health, Public Policy, and Economics

Dissemination of the Rx for Change in Psychiatry Curriculum	2008 (Cycle 17)	$409,106
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Association of Outlet Density with Smoking and Pack Price	2008 (Cycle 17)	$515,010
Stanford University	Public Health, Public Policy, and Economics

Novel Extracellular Sulfatases and Smoke-induced Lung Cancer	2008 (Cycle 17)	$394,380
University of California, San Francisco	Cancer

Nicotinic receptors in nicotine addiction	2008 (Cycle 17)	$634,743
California Institute of Technology	Nicotine Dependence

Negative effects of smoke on novel HDL mimetic therapies	2008 (Cycle 17)	$657,970
Lawrence Berkeley National Laboratory	Cardiovascular Disease

Measuring prenatal tobacco exposure in newborn blood spots	2008 (Cycle 17)	$506,839
Sequoia Foundation	Epidemiology

Chronic nicotine treatment in primates; role of a6b2 nAChRs	2008 (Cycle 17)	$382,500
SRI International	Nicotine Dependence

Smokefree Homes and Smoking Initiation in a National Sample	2008 (Cycle 17)	$477,781
University of California, San Diego	Public Health, Public Policy, and Economics

Smoking Policies and Secondhand Smoke in Hotel Rooms	2008 (Cycle 17)	$522,544
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Analysis of the Hippo pathway in lung cancer	2008 (Cycle 17)	$654,999
Beckman Research Institute of the City of Hope	Cancer

Chronic nicotine treatment in primates; role of a6b2 nAChRs	2008 (Cycle 17)	$194,628
The Parkinson's Institute	Nicotine Dependence

ApoE related effect of smoking in cardiovascular disease	2008 (Cycle 17)	$678,561
Children's Hospital Oakland Research Institute	Cardiovascular Disease

Dissemination of the Rx for Change in Psychiatry Curriculum	2008 (Cycle 17)	$30,177
Stanford University	Tobacco-Use Prevention and Cessation

Role of oxidative stress and mitochondria in COPD	2008 (Cycle 17)	$615,251
University of Southern California	General Biomedical Science

Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer	2008 (Cycle 17)	$654,674
Beckman Research Institute of the City of Hope	Cancer

Pharmacogenomics of New Generation Platinums in Lung Cancer	2008 (Cycle 17)	$394,380
University of California, San Francisco	Cancer

Low-Cost Contingency Management for Smoking Cessation	2008 (Cycle 17)	$478,743
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Cigarette smoke injures lung epithelium by activating nSMase	2008 (Cycle 17)	$394,380
University of California, Davis	Pulmonary Disease

The impact of secondhand smoke exposure on COPD outcomes	2008 (Cycle 17)	$492,890
University of California, San Francisco	Epidemiology

Nicotine Self-Administration in an Animal Model	2008 (Cycle 17)	$720,434
Scripps Research Institute	Nicotine Dependence

Nicotine and congenital heart disease	2008 (Cycle 17)	$629,797
Stanford University	Cardiovascular Disease

Nicotinic Manipulation of the Hippocampus	2007 (Cycle 16)	$420,000
University of California, San Diego	Nicotine Dependence

Tobacco Industry Targeting of Older Persons	2007 (Cycle 16)	$509,993
University of California, San Francisco	Public Health, Public Policy, and Economics

Modulating TLR9 Activation for Lung Cancer Therapy	2007 (Cycle 16)	$415,463
The Burnham Institute for Medical Research	Cancer

Social Context of Smoking in Adolescence and Young Adulthood	2007 (Cycle 16)	$791,718
RAND Corporation	Epidemiology

Impact of MPO in Tobacco-related Cardiovascular Disease	2007 (Cycle 16)	$545,359
Sidney Kimmel Cancer Center	Cardiovascular Disease

Exposure to Secondhand Smoke: Effects of Proximity	2007 (Cycle 16)	$628,932
Stanford University	Public Health, Public Policy, and Economics

Modulating TLR9 Activation for Lung Cancer Therapy	2007 (Cycle 16)	$246,467
Scripps Research Institute	Cancer

Brain nAChR Occupancy: Effect of Secondhand Smoke	2007 (Cycle 16)	$623,593
Brentwood Biomedical Research Institute	Nicotine Dependence

Economic Impact of Secondhand Smoke for Communities of Color	2007 (Cycle 16)	$216,038
University of California, San Francisco	Public Health, Public Policy, and Economics

Modulating TLR9 Activation for Lung Cancer Therapy	2007 (Cycle 16)	$100,481
Sidney Kimmel Cancer Center	Cancer

Macrophage DAP12 pathway in emphysema	2007 (Cycle 16)	$387,237
University of California, San Francisco	Pulmonary Disease

Molecular Dynamics & Regulation of Apo A-I's Conformation	2007 (Cycle 16)	$644,293
Children's Hospital Oakland Research Institute	Cardiovascular Disease

Effects of nicotine on fetal hematopoiesis	2007 (Cycle 16)	$764,400
Torrey Pines Institute for Molecular Studies	General Biomedical Science

High Resolution OCT for Early Airway Cancer Detection	2007 (Cycle 16)	$480,636
University of California, Irvine	Cancer

Understanding Nicotinic Receptor Subtype Specificity	2007 (Cycle 16)	$592,751
California Institute of Technology	Nicotine Dependence

Impact of MPO in Tobacco-related Cardiovascular Disease	2007 (Cycle 16)	$267,555
The Burnham Institute for Medical Research	Cardiovascular Disease

Hypnosis for Smoking Relapse Prevention	2007 (Cycle 16)	$506,230
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Epigenetic Regulation of Airway MUC gene expression by smoke	2007 (Cycle 16)	$419,528
University of California, Davis	Pulmonary Disease

Toxic and irritant pollutants from aged secondhand smoke	2007 (Cycle 16)	$715,914
Lawrence Berkeley National Laboratory	General Biomedical Science

Gastroschisis: maternal smoking and genetic variation	2007 (Cycle 16)	$668,429
Children's Hospital Oakland Research Institute	General Biomedical Science

Pharmacogenetics of Smoking Cessation	2006 (Cycle 15)	$653,384
Stanford University	Tobacco-Use Prevention and Cessation

Culture and Tobacco Among American Indian Adolescents	2006 (Cycle 15)	$824,825
University of Southern California	Epidemiology

Effect of Maternal Smoking on Early Human Development	2006 (Cycle 15)	$489,025
University of California, San Francisco	General Biomedical Science

Activation and detoxification of lung cancer carcinogens	2006 (Cycle 15)	$420,000
University of California, San Diego	Cancer

Immune Targeted Therapy for Lung Cancer	2006 (Cycle 15)	$419,500
University of California, Los Angeles	Cancer

Genes affecting nicotine response in C. elegans	2006 (Cycle 15)	$100,000
University of California, San Diego	Nicotine Dependence

Cotinine Metabolism in Infants and Children	2006 (Cycle 15)	$509,473
University of California, San Francisco	Public Health, Public Policy, and Economics

Unraveling lung cancer signaling pathways	2006 (Cycle 15)	$780,780
Scripps Research Institute	Cancer

Simple Exposure Indicators for Secondhand Tobacco Smoke	2006 (Cycle 15)	$280,684
Lawrence Berkeley National Laboratory	General Biomedical Science

Nicotine-dependent recruitment of vascular progenitor cells	2006 (Cycle 15)	$799,907
The Burnham Institute for Medical Research	Cardiovascular Disease

NF-kB mediated inflammation in tobacco-induced lung cancer	2006 (Cycle 15)	$420,000
University of California, San Diego	Cancer

Neurobiological substrates of nicotine addiction	2006 (Cycle 15)	$419,503
University of California, San Diego	Nicotine Dependence

Clinical Pharmacology of Tobacco Alkaloids	2006 (Cycle 15)	$508,848
University of California, San Francisco	General Biomedical Science

Smoking Policies and Secondhand Smoke in Rental Cars	2006 (Cycle 15)	$609,852
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Sociocultural Determinants of Menthol Smoking Among Blacks	2006 (Cycle 15)	$746,567
Charles R. Drew University of Medicine & Science	Epidemiology

Oxidative stress and skeletal muscle dysfunction in COPD	2006 (Cycle 15)	$569,914
University of California, San Diego	Pulmonary Disease

Sex differences in nicotine effects on inflammation	2006 (Cycle 15)	$410,570
University of California, San Francisco	Cardiovascular Disease

Mechanisms of targeted therapy resistance in lung cancer	2006 (Cycle 15)	$358,500
University of California, Los Angeles	Cancer

Use of Existing Data to Develop Tobacco Control Strategies	2006 (Cycle 15)	$418,699
University of California, San Diego	Public Health, Public Policy, and Economics

Reaching and Treating LGBT Smokers: The Internet and NRT	2006 (Cycle 15)	$509,201
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Heparan sulfate small molecules for contro tumor cell growth	2005 (Cycle 14)	$626,807
California Institute of Technology	General Biomedical Science

Human oocyte development and PAH exposure	2005 (Cycle 14)	$158,034
Stanford University	General Biomedical Science

Nicotine & behavioral regulation in adult ADHD	2005 (Cycle 14)	$495,079
University of California, Irvine	Tobacco-Use Prevention and Cessation

Diabetes & tobacco exposure in So CA American Indians	2005 (Cycle 14)	$468,020
University of California, San Diego	Epidemiology

Effects of Outlet/Ad Density on Teen Smking and Brand Choice	2005 (Cycle 14)	$410,979
Stanford University	Public Health, Public Policy, and Economics

Role of Pneumocystis in COPD Progression	2005 (Cycle 14)	$512,737
University of Southern California	Pulmonary Disease

Use of entertainment education on TV to deter youth smoking	2005 (Cycle 14)	$509,320
University of California, Irvine	Public Health, Public Policy, and Economics

Improved chemoradiotherapy of lung cancer	2005 (Cycle 14)	$659,033
California Pacific Medical Center Research Institute	Cancer

ETS Effects on Lung Surfactant	2005 (Cycle 14)	$418,874
University of California, Santa Barbara	General Biomedical Science

Regulations of phase II genes by oxidation products	2005 (Cycle 14)	$419,057
University of California, Merced	General Biomedical Science

Human oocyte development and PAH exposure	2005 (Cycle 14)	$260,944
University of California, San Francisco	General Biomedical Science

A stage-based scheduled smoking intervention for Chinese	2005 (Cycle 14)	$554,500
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Context & consequenes of smoking in a blue-collar cohort	2005 (Cycle 14)	$426,555
Pacific Institute for Research and Evaluation	Epidemiology

cGMP regulation of vascular smooth muscle differentiation	2005 (Cycle 14)	$403,818
University of California, San Diego	Cardiovascular Disease

Neuronal oxidative stress from mild carbon monoxide exposure	2005 (Cycle 14)	$417,403
University of California, Los Angeles	General Biomedical Science

Mild carbon monoxide exposure impairs the inner ear	2005 (Cycle 14)	$397,297
University of California, Los Angeles	General Biomedical Science

Role of protein phosphatase 2A in lung cancer	2005 (Cycle 14)	$384,497
University of California, San Diego	Cancer

Relationship of perceived risks and benefits to teen smoking	2005 (Cycle 14)	$532,037
University of California, San Francisco	Epidemiology

A novel approach to prevent in utero nicotine lung injury	2005 (Cycle 14)	$597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center	General Biomedical Science

Conformationally constrained nicotine vaccines	2005 (Cycle 14)	$778,921
Scripps Research Institute	Nicotine Dependence

Effect of smoke and gender on bronchiolar injury and repair	2005 (Cycle 14)	$418,207
University of California, Davis	Pulmonary Disease

SHS Exacerbates cerebral ischemia: endothelial mechanisms	2005 (Cycle 14)	$654,849
Stanford University	Cardiovascular Disease

COX-2 regulation of vaccination responses in lung cancer	2004 (Cycle 13)	$379,362
University of California, Los Angeles	Cancer

Lesbian, gay, bisexual and transgender tobacco use	2004 (Cycle 13)	$302,119
Kaiser Foundation Research Institute	Epidemiology

Lifetime passive smoke exposure and breast cancer in the CTS	2004 (Cycle 13)	$285,300
Cancer Prevention Institute of California	Epidemiology

Internet health research center: smoking, Latinos, & the Web	2004 (Cycle 13)	$535,096
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Disproportionate cost of smoking for communities of color	2004 (Cycle 13)	$278,980
University of California, San Francisco	Public Health, Public Policy, and Economics

Women and smoking: from adolescence to young adulthood	2004 (Cycle 13)	$737,742
RAND Corporation	Epidemiology

Effects of tobacco-induced gamete damage on embryogenesis	2004 (Cycle 13)	$158,853
Lawrence Livermore National Laboratory	General Biomedical Science

Tobacco exposure in pregnant women in minority populations	2004 (Cycle 13)	$469,727
Sequoia Foundation	Epidemiology

SHS enhances cough via plasticity of brainstem neurons	2004 (Cycle 13)	$387,150
University of California, Davis	Pulmonary Disease

Ethnicity and school-level effect on CA student tobacco use	2004 (Cycle 13)	$420,713
University of California, Los Angeles	Epidemiology

Supply & demand for tobacco dependence coverage	2004 (Cycle 13)	$89,145
University of California, Berkeley	Public Health, Public Policy, and Economics

Environmental contexts of smoking for Southeast Asians	2004 (Cycle 13)	$726,834
Pacific Institute for Research and Evaluation	Epidemiology

Effects of tobacco-induced gamete damage on embryogenesis	2004 (Cycle 13)	$607,787
Lawrence Berkeley National Laboratory	General Biomedical Science

Nonsmokers helping smokers and the role of culture	2004 (Cycle 13)	$476,656
University of California, San Diego	Tobacco-Use Prevention and Cessation

Fertility smoking and early mammalian development	2004 (Cycle 13)	$392,451
University of California, Riverside	General Biomedical Science

Vitamin A derivatives as antagonists of nicotine effects	2004 (Cycle 13)	$670,085
The Burnham Institute for Medical Research	Cancer

Corporate strategies: design, conduct, publication of research	2004 (Cycle 13)	$407,567
University of California, San Francisco	Public Health, Public Policy, and Economics

How do nic and cig smoke affect neural control of breathing?	2004 (Cycle 13)	$392,620
University of California, Los Angeles	Pulmonary Disease

Lifetime passive smoke exposure and breast cancer in the CTS	2004 (Cycle 13)	$122,659
Public Health Institute	Epidemiology

Exposed children to secondhand smoke through contaminated homes	2004 (Cycle 13)	$754,504
San Diego State University Research Foundation	Epidemiology

Effects of pro and anti-smoking cues in stores on craving	2004 (Cycle 13)	$373,894
Stanford University	Public Health, Public Policy, and Economics

IAP Antagonists for lung cancer treatment	2004 (Cycle 13)	$727,658
The Burnham Institute for Medical Research	Cancer

Preserving at-risk tobacco control policy resources	2004 (Cycle 13)	$392,344
University of California, San Francisco	Public Health, Public Policy, and Economics

Tobacco use and atherosclerosis protection by paraoxonase	2004 (Cycle 13)	$729,234
Scripps Research Institute	Cardiovascular Disease

Oral clefts, smoking & variation of toxin biotransformation	2004 (Cycle 13)	$623,472
Children's Hospital Oakland Research Institute	General Biomedical Science

Effectiveness of a large prenatal tobacco reduction program	2004 (Cycle 13)	$425,181
Sequoia Foundation	Epidemiology

The role of PARC in pulmonary inflammation	2004 (Cycle 13)	$812,863
La Jolla Institute for Molecular Medicine	Pulmonary Disease

Smoking cessation and medical care use/costs in a large HMO	2003 (Cycle 12)	$337,964
University of California, San Francisco	Public Health, Public Policy, and Economics

Passive smoking, inflammatory markers and childhood asthma	2003 (Cycle 12)	$508,299
University of California, San Diego	Epidemiology

Nicotine self-administration in an animal model	2003 (Cycle 12)	$660,156
Scripps Research Institute	Nicotine Dependence

Novel Office-Based Device for Imaging Vocal Cord Cancer	2003 (Cycle 12)	$510,000
University of California, Irvine	Cancer

LDL pathophysiology and lipoprotein structure	2003 (Cycle 12)	$527,245
Children's Hospital Oakland Research Institute	Cardiovascular Disease

Tobacco smoke and airway remodeling in asthma	2003 (Cycle 12)	$418,951
University of California, San Diego	Pulmonary Disease

Does tobacco exposure delay conception?	2003 (Cycle 12)	$447,845
Sequoia Foundation	Epidemiology

Bupropion for hospital-based smoking cessation	2003 (Cycle 12)	$478,065
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Correlates of cigarette craving in acute nicotine withdrawal	2003 (Cycle 12)	$17,000
University of California, Los Angeles	Nicotine Dependence

Birth defects, smoking and host susceptibility	2003 (Cycle 12)	$466,200
March of Dimes Birth Defects Foundation	Epidemiology

Hyperactive nicotine receptors	2003 (Cycle 12)	$675,487
California Institute of Technology	Nicotine Dependence

Chemotherapeutic inhibition of polysialic acid biosynthesis	2003 (Cycle 12)	$420,781
University of California, Davis	Cancer

Effect of maternal smoking on early human development	2003 (Cycle 12)	$505,975
University of California, San Francisco	General Biomedical Science

Correlates of cigarette craving in acute nicotine withdrawal	2003 (Cycle 12)	$517,818
Brentwood Biomedical Research Institute	Nicotine Dependence

California AB13 compliance and ethnicity in urban bars	2003 (Cycle 12)	$769,266
Pacific Institute for Research and Evaluation	Public Health, Public Policy, and Economics

Controlled study of withdrawal symptoms in teen smokers	2003 (Cycle 12)	$499,890
Stanford University	Nicotine Dependence

Smoking prevention for Asian-American college students	2003 (Cycle 12)	$679,368
Veterans Medical Research Foundation	Tobacco-Use Prevention and Cessation

Neurobiological substrates of nicotine addiction	2003 (Cycle 12)	$723,613
Scripps Research Institute	Nicotine Dependence

Use of existing data to dvlp new tobacco control strategies	2003 (Cycle 12)	$419,888
University of California, San Diego	Public Health, Public Policy, and Economics

Integrins and drug resistance in small cell lung cancer	2003 (Cycle 12)	$780,144
The Burnham Institute for Medical Research	Cancer

Protective function of VEGF on the development of emphysema	2003 (Cycle 12)	$420,000
University of California, San Diego	Pulmonary Disease

Novel DNA vaccines for the treatment of lung cancer	2003 (Cycle 12)	$783,900
Scripps Research Institute	Cancer

Tobacco use among American Indian adolescents in California	2003 (Cycle 12)	$368,975
University of Southern California	Epidemiology

Geography of underage tobacco retail sales in Los Angeles	2003 (Cycle 12)	$622,260
Pacific Institute for Research and Evaluation	Public Health, Public Policy, and Economics

Smoking, insulin resistance, and endothelial dysfunction	2003 (Cycle 12)	$814,989
Stanford University	Cardiovascular Disease

Irritant and analgesic effects of nicotine	2002 (Cycle 11)	$226,650
University of California, Davis	Nicotine Dependence

Tobacco Alteration of TGF Beta3 Control of Palatogenesis	2002 (Cycle 11)	$680,175
University of Southern California	General Biomedical Science

Nicotine and cardiac vulnerability to fibrillation	2002 (Cycle 11)	$641,821
Cedars-Sinai Medical Center	Cardiovascular Disease

Environmental tobacco smoke effects on lung surfactant	2002 (Cycle 11)	$406,444
University of California, Santa Barbara	Pulmonary Disease

Role of protein phosphatase 2A in lung cancer	2002 (Cycle 11)	$405,795
University of California, San Diego	Cancer

Internet-enhanced proactive telephone counseling	2002 (Cycle 11)	$674,731
Veterans Medical Research Foundation	Tobacco-Use Prevention and Cessation

The geography of tobacco related disease in California	2002 (Cycle 11)	$374,786
Pacific Institute for Research and Evaluation	Epidemiology

Nicotine-pathological angiogenesis and genetic determinants	2002 (Cycle 11)	$608,420
Stanford University	Cardiovascular Disease

Modeling cost/effectiveness of tobacco control programs	2002 (Cycle 11)	$129,915
University of California, San Diego	Public Health, Public Policy, and Economics

Effect of tobacco-related policy change on smoking behavior	2002 (Cycle 11)	$303,504
University of California, San Diego	Public Health, Public Policy, and Economics

Nicotinic receptors and Parkinson's disease	2002 (Cycle 11)	$376,470
The Parkinson's Institute	Nicotine Dependence

Effect of smoke and gender on bronchiolar injury and repair	2002 (Cycle 11)	$413,288
University of California, Davis	Pulmonary Disease

Molecular predictors of oral cancer development	2002 (Cycle 11)	$419,000
University of California, San Francisco	Cancer

Inflammation, innate immunity, TLRs, and atherosclerosis	2002 (Cycle 11)	$697,650
Scripps Research Institute	Cardiovascular Disease

Modeling cost/effectiveness of tobacco control programs	2002 (Cycle 11)	$23,238
University of California, Los Angeles	Public Health, Public Policy, and Economics

Smoking and variation of cardiovascular disease genes	2002 (Cycle 11)	$635,131
Children's Hospital Oakland Research Institute	Epidemiology

Nicotinic receptors, smoking and Parkinson's Disease	2002 (Cycle 11)	$765,971
Stanford University	Epidemiology

Simple exposure indicators for ETS particles	2002 (Cycle 11)	$749,647
Lawrence Berkeley National Laboratory	General Biomedical Science

Prenatal smoke exposure and age at menarche	2002 (Cycle 11)	$129,090
Sequoia Foundation	Epidemiology

Brain imaging in nicotine addiction	2002 (Cycle 11)	$419,881
University of California, Los Angeles	Nicotine Dependence

Immunopharmacotherapy as a treatment for nicotine addiction	2002 (Cycle 11)	$515,270
Scripps Research Institute	Nicotine Dependence

Smoking induced dopamine release: buproprion effects	2002 (Cycle 11)	$659,060
Brentwood Biomedical Research Institute	Nicotine Dependence

Cardiac ion channels and tobacco-related disease	2002 (Cycle 11)	$389,983
University of California, Santa Barbara	Cardiovascular Disease

Vascular targeting of lung tumors	2002 (Cycle 11)	$830,563
Sidney Kimmel Cancer Center	Cancer

p53 and p14ARF: Multiple pathways of lung cancer suppression	2002 (Cycle 11)	$821,050
Sidney Kimmel Cancer Center	Cancer

Tobacco prevention/cessation at continuation schools	2002 (Cycle 11)	$848,679
University of Southern California	Tobacco-Use Prevention and Cessation

Novel agents for apoptosis of lung cancer	2002 (Cycle 11)	$787,977
The Burnham Institute for Medical Research	Cancer

Pager-assisted smoking cessation treatment	2002 (Cycle 11)	$463,689
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Tobacco industry responses to industry-focused campaigns	2002 (Cycle 11)	$77,806
University of California, San Francisco	Public Health, Public Policy, and Economics

Tobacco use & policies: San Diego Mexican American residents	2002 (Cycle 11)	$786,750
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Model for surveillance of CA tobacco control policies	2001 (Cycle 10)	$325,761
Pacific Institute for Research and Evaluation	Public Health, Public Policy, and Economics

Smoking and virulence of periodontal pathogens	2001 (Cycle 10)	$289,574
Loma Linda University	General Biomedical Science

Mechanism of smoke-induced MUC5B gene expression	2001 (Cycle 10)	$392,117
University of California, Davis	Pulmonary Disease

Anabolic therapies for muscle dysfunction in women with COPD	2001 (Cycle 10)	$632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Pulmonary Disease

Neurobehavioral consequences of adolescent nicotine exposure	2001 (Cycle 10)	$630,710
Scripps Research Institute	Nicotine Dependence

Transdermal nicotine for smokers with schizophrenia	2001 (Cycle 10)	$640,429
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Tobacco-Use Prevention and Cessation

Effects of nicotine withdrawal on aviator performance	2001 (Cycle 10)	$515,243
Stanford University	Nicotine Dependence

Patterns of tobacco use from adolescence to young adulthood	2001 (Cycle 10)	$431,132
RAND Corporation	Epidemiology

Smoking, microsatellite instability & gastric cancers	2001 (Cycle 10)	$729,199
University of Southern California	Epidemiology

Smoking and the pathogenesis of macular degeneration	2001 (Cycle 10)	$316,038
University of California, Santa Barbara	General Biomedical Science

Clinical pharmacology of tobacco alkaloids	2001 (Cycle 10)	$373,408
University of California, San Francisco	General Biomedical Science

Chemokine-based therapy for lung cancer	2001 (Cycle 10)	$416,940
University of California, Los Angeles	Cancer

Persistent smoking in bars: an ethnographic analysis	2001 (Cycle 10)	$482,317
Pacific Institute for Research and Evaluation	Public Health, Public Policy, and Economics

Analysis of a lung tumor supressor gene at 3p21.3	2001 (Cycle 10)	$249,438
Beckman Research Institute of the City of Hope	Cancer

Fertility, smoking and early mammalian development	2001 (Cycle 10)	$454,490
University of California, Riverside	General Biomedical Science

Neurobiological substrates of nicotine addiction	2001 (Cycle 10)	$402,852
Scripps Research Institute	Nicotine Dependence

Adolescent susceptibility to tobacco: a panel analysis	2001 (Cycle 10)	$495,433
University of California, Irvine	Epidemiology

Mechanisms underlying modulations of respiration by nicotine	2001 (Cycle 10)	$330,458
University of California, Los Angeles	Pulmonary Disease

Nicotine withdrawal, smoking & attention: an fMRI study	2001 (Cycle 10)	$515,303
University of California, Los Angeles	Nicotine Dependence

Molecular neurobiology of nicotine addiction	2001 (Cycle 10)	$263,298
University of California, Los Angeles	Nicotine Dependence

Smoking prevention for Asian-American college students	2001 (Cycle 10)	$588,595
Veterans Medical Research Foundation	Epidemiology

Novel regulatory mechanisms for lung cancer growth	2001 (Cycle 10)	$620,032
Veterans Medical Research Foundation	Cancer

Two approaches to referral for smoking cessation treatment	2001 (Cycle 10)	$496,836
University of California, Los Angeles	Tobacco-Use Prevention and Cessation

Environmental tobacco smoke exposure & adult asthma	2001 (Cycle 10)	$460,032
University of California, San Francisco	Epidemiology

Tobacco smoke, inflammation & atherosclerosis	2001 (Cycle 10)	$754,932
Scripps Research Institute	Cardiovascular Disease

ApoE isoforms, fatty acid metabolism and atherosclerosis	2001 (Cycle 10)	$691,616
J. David Gladstone Institutes	Cardiovascular Disease

Bispecific molecular therapy of small cell lung cancer	2001 (Cycle 10)	$434,805
University of California, San Diego	Cancer

Self-hypnosis for smoking cessation	2001 (Cycle 10)	$413,119
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Smoking-induced oxidant stress & platelet integrin alpha....	2001 (Cycle 10)	$801,893
The Burnham Institute for Medical Research	Cardiovascular Disease

Cardiovascular responses through spinal nicotinic receptors	2001 (Cycle 10)	$448,941
University of California, San Diego	Nicotine Dependence

The role of media in smoking initiation & cessation	2001 (Cycle 10)	$414,203
University of California, San Diego	Public Health, Public Policy, and Economics

Analysis of California adolescent tobacco data	2001 (Cycle 10)	$475,742
University of California, Los Angeles	Epidemiology

Dysregulation of VSMC signaling induced by nicotine	2001 (Cycle 10)	$683,510
Stanford University	Cardiovascular Disease

Effect of tobacco smoke on leucocyte adhesion in vivo	2001 (Cycle 10)	$1,023,946
La Jolla Institute for Molecular Medicine	Pulmonary Disease

Spanish/English web site for smoking cessation trials	2001 (Cycle 10)	$519,674
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Improved therapy of lung cancer	2000 (Cycle 9)	$668,814
California Pacific Medical Center Research Institute	Cancer

RCT of tobacco dependence treatment benefits in an HMO & PPO	2000 (Cycle 9)	$582,472
University of California, Berkeley	Public Health, Public Policy, and Economics

Novel nicotine cessation therapeutics	2000 (Cycle 9)	$802,840
Human BioMolecular Research Institute	Nicotine Dependence

Human neurophysiology of nicotine analgesia: sex differences	2000 (Cycle 9)	$595,994
University of California, San Francisco	Nicotine Dependence

Tobacco industry targeting of African Americans	2000 (Cycle 9)	$99,680
University of California, San Francisco	Public Health, Public Policy, and Economics

Experimental evaluation of minors' access to tobacco	2000 (Cycle 9)	$655,347
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Novel regulatory mechanisms for lung cancer growth	2000 (Cycle 9)	$100,000
University of California, San Diego	Cancer

Predicting progress toward cessation in California smokers	2000 (Cycle 9)	$99,954
University of California, San Diego	Public Health, Public Policy, and Economics

DNA replication, regulation of the cell cycle, and cancer	2000 (Cycle 9)	$571,742
California Institute of Technology	General Biomedical Science

Nicotinic and Schizophrenia	2000 (Cycle 9)	$87,719
University of California, Irvine	Nicotine Dependence

Chronic bronchitis: pathology of mucin gene expression	2000 (Cycle 9)	$147,758
University of California, San Francisco	Pulmonary Disease

Implementation of tobacco programs in California schools	2000 (Cycle 9)	$765,192
University of Southern California	Public Health, Public Policy, and Economics

A dynamic model of smoking and healthcare expenditures in CA	2000 (Cycle 9)	$595,843
University of California, San Francisco	Public Health, Public Policy, and Economics

The role of media in smoking initiation & cessation	2000 (Cycle 9)	$98,395
University of California, San Diego	Public Health, Public Policy, and Economics

Chronic bronchitis: pathology of mucin gene expression	2000 (Cycle 9)	$329,481
University of California, Davis	Pulmonary Disease

Tobacco use & acculturation: CA residents of Korean descent	2000 (Cycle 9)	$825,701
San Diego State University Research Foundation	Epidemiology

Pathophysiology of abnormal remnant metabolism in smokers	2000 (Cycle 9)	$783,345
Palo Alto Medical Foundation Research Institute	Cardiovascular Disease

Role of Smad protein in growth inhibition of tumor cells	2000 (Cycle 9)	$474,492
Lawrence Berkeley National Laboratory	Cancer

Comprehensive evaluation of the ischemic leg	2000 (Cycle 9)	$672,390
Stanford University	General Biomedical Science

Lung volume reduction surgery in an animal emphysema model	2000 (Cycle 9)	$456,336
University of California, Irvine	Pulmonary Disease

Studies of novel antitumor agents for lung carcinoma	2000 (Cycle 9)	$833,491
University of California, San Diego	Cancer

Mobilized dendritic cells for lung cancer	2000 (Cycle 9)	$950,821
Stanford University	Cancer

Behavioral effects of neonatal nicotine exposure	2000 (Cycle 9)	$624,780
San Diego State University Research Foundation	Nicotine Dependence

Molecular origins of apoB atherogenic lipoproteins	2000 (Cycle 9)	$445,617
University of California, San Francisco	Cardiovascular Disease

Determinants of smoking among gay & lesbian youth	2000 (Cycle 9)	$509,771
University of California, San Francisco	Epidemiology

Dissuading at-risk youth from smoking via mass media	2000 (Cycle 9)	$610,340
University of California, Irvine	Tobacco-Use Prevention and Cessation

Role of integrins in cardiac innervation and function	2000 (Cycle 9)	$293,277
University of California, Santa Barbara	Cardiovascular Disease

Use of existing data to develop new tobacco control strategies	2000 (Cycle 9)	$402,610
University of California, San Diego	Public Health, Public Policy, and Economics

Tests of the tobacco industry's youth smoking prevention ads	2000 (Cycle 9)	$343,044
Stanford University	Public Health, Public Policy, and Economics

Mechanism of nicotine action in developing lung	2000 (Cycle 9)	$720,281
University of Southern California	Pulmonary Disease

Tobacco exposure & subclinical atherosclerosis in NIDDM	2000 (Cycle 9)	$321,363
University of Southern California	Epidemiology

Smoking, estrogen metabolites & cognitive function	2000 (Cycle 9)	$193,049
University of California, San Diego	Epidemiology

CT imaging to assist diagnosis of solitary pulmonary nodules	2000 (Cycle 9)	$59,002
University of California, Los Angeles	Cancer

ETS effects on breathing patterns	2000 (Cycle 9)	$590,780
University of California, Davis	Pulmonary Disease

Recruitment of leucocytes to atherosclerotic lesions in vivo	2000 (Cycle 9)	$175,102
University of California, San Diego	Cardiovascular Disease

Nicotine & cardiac vulnerability to fibrillation	2000 (Cycle 9)	$120,000
Cedars-Sinai Medical Center	Cardiovascular Disease

Proposition 99 Archives	2000 (Cycle 9)	$100,000
University of California, San Francisco	Public Health, Public Policy, and Economics

Analysis of a candidate lung tumor suppressor gene at 3p21.3	2000 (Cycle 9)	$111,910
Beckman Research Institute of the City of Hope	Cancer

Smoking & the pathogenesis of macular degeneration	2000 (Cycle 9)	$99,500
University of California, Santa Barbara	General Biomedical Science

Novel DNA vaccines for the treatment of lung cancer	2000 (Cycle 9)	$1,063,300
Scripps Research Institute	Cancer

Nicotine regulates cardiac toxicity with lipopolysaccharide	2000 (Cycle 9)	$100,000
University of California, San Diego	Cardiovascular Disease

Telephone counseling for smokers using pharmacotherapy	2000 (Cycle 9)	$774,971
University of California, San Diego	Tobacco-Use Prevention and Cessation

Nicotine in the Brain	2000 (Cycle 9)	$518,966
University of California, San Diego	Nicotine Dependence

Human tryptase gene expression: role in COPD	2000 (Cycle 9)	$545,409
University of California, San Francisco	Pulmonary Disease

Analysis of tobacco industry documents on scientific research	2000 (Cycle 9)	$442,646
University of California, San Francisco	Public Health, Public Policy, and Economics

Nicotine effects on renal function in experimental diabetes	2000 (Cycle 9)	$98,313
University of California, San Diego	Cardiovascular Disease

Neurobehavioral consequences of adolescent nicotine exposure	2000 (Cycle 9)	$120,000
Scripps Research Institute	Nicotine Dependence

Stress and the use of nicotine	2000 (Cycle 9)	$897,484
Cedars-Sinai Medical Center	Nicotine Dependence

Hyperactive nicotine receptors	2000 (Cycle 9)	$1,138,225
California Institute of Technology	Nicotine Dependence

Proteins involved in nicotine receptor clustering	2000 (Cycle 9)	$307,246
University of California, San Diego	Nicotine Dependence

Effects of prenatal nicotine exposure on nicotinic receptors	2000 (Cycle 9)	$471,654
University of California, San Francisco	Nicotine Dependence

Macrophage function in atherosclerosis	2000 (Cycle 9)	$709,200
Scripps Research Institute	Cardiovascular Disease

Post-isoprenylation processing steps as anticancer targets	2000 (Cycle 9)	$1,017,450
J. David Gladstone Institutes	Cancer

Effect of maternal smoking on human placental development	2000 (Cycle 9)	$515,124
University of California, San Francisco	General Biomedical Science

Cytokine gene-modified dendritic cells for lung cancer	2000 (Cycle 9)	$590,523
University of California, Los Angeles	Cancer

Effects of passive smoking and pregnancy	1999 (Cycle 8)	$565,186
Lawrence Livermore National Laboratory	Cancer

Dissemination of a smoking cessation program for in patients	1999 (Cycle 8)	$710,621
Stanford University	Tobacco-Use Prevention and Cessation

Effect of tobacco related policy change on smoking behavior	1999 (Cycle 8)	$261,672
University of California, San Diego	Public Health, Public Policy, and Economics

Parkinson's Disease: A Protective Effect of Smoking?	1999 (Cycle 8)	$512,849
Stanford University	Epidemiology

Evaluation of office ETS exposure in relation to AB13	1999 (Cycle 8)	$208,554
Lawrence Berkeley National Laboratory	General Biomedical Science

African Americans and Mentholated Cigarettes	1999 (Cycle 8)	$417,968
Charles R. Drew University of Medicine & Science	Nicotine Dependence

Ethnic difference in cigarette smoking dynamics among youth	1999 (Cycle 8)	$366,852
University of Southern California	Epidemiology

Tobacco Control Digital Library	1999 (Cycle 8)	$514,796
University of California, San Francisco	Public Health, Public Policy, and Economics

Neurotransmitter systems and tobacco smoking	1999 (Cycle 8)	$430,910
University of California, Los Angeles	Nicotine Dependence

Neurotoxic effects of nicotine: anatomy, mechanisms, effects	1999 (Cycle 8)	$183,424
University of California, Los Angeles	Nicotine Dependence

Evaluation of office ETS exposure in relation to AB 13	1999 (Cycle 8)	$242,063
Public Health Institute	Public Health, Public Policy, and Economics

Role of protein phosphatase 2A in lung cancer	1999 (Cycle 8)	$307,522
University of California, San Diego	Cancer

Explaining racial differences in smoking	1999 (Cycle 8)	$149,280
Public Health Foundation Enterprises, Inc.	Public Health, Public Policy, and Economics

Smoking, breast cancer and tobacco metabolizing genes	1999 (Cycle 8)	$120,000
Childrens Hospital, Los Angeles	Epidemiology

Supplement to tobacco disease in twins	1999 (Cycle 8)	$432,989
University of Southern California	Epidemiology

Telephone Counseling for Pregnant Smokers	1999 (Cycle 8)	$828,931
University of California, San Diego	Tobacco-Use Prevention and Cessation

Smoking Control Policies in California Health Plans	1999 (Cycle 8)	$80,542
University of California, Berkeley	Public Health, Public Policy, and Economics

Effectiveness of two different regimens in smoking clinic	1999 (Cycle 8)	$272,989
University of California, Los Angeles	Nicotine Dependence

Nicotine May Affect Inflammation	1999 (Cycle 8)	$435,425
University of California, San Francisco	Nicotine Dependence

Tobacco oxidants and the ceramide path in lung cell death	1999 (Cycle 8)	$427,613
University of California, Davis	Pulmonary Disease

Novel strategy for protecting neurons from injury in stroke	1999 (Cycle 8)	$742,809
Stanford University	Cardiovascular Disease

Vascular targeting of lung tumors	1999 (Cycle 8)	$899,686
Sidney Kimmel Cancer Center	Cancer

A longitudinal study of smoking transitions in youth	1999 (Cycle 8)	$577,574
University of California, San Diego	Tobacco-Use Prevention and Cessation

Smoking during pregnancy: chromosome damage in newborns	1999 (Cycle 8)	$1,662,871
Lawrence Livermore National Laboratory	Epidemiology

Detection of occult metastases in patients with lung cancer	1999 (Cycle 8)	$723,842
University of Southern California	Cancer

Ascertainment of environmental tobacco exposure in pregnancy	1999 (Cycle 8)	$2,053,747
Sequoia Foundation	Epidemiology

Economic Analysis of Smoking Cessation Therapies	1999 (Cycle 8)	$270,206
University of California, San Francisco	Public Health, Public Policy, and Economics

Role of nicotine in neuro protection	1999 (Cycle 8)	$722,263
The Parkinson's Institute	Nicotine Dependence

Explaining racial differences in smoking	1999 (Cycle 8)	$151,430
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Nicotine effects on neurological development	1999 (Cycle 8)	$189,233
University of California, Irvine	Nicotine Dependence

Environmental tobacco smoke effects on lung surfactant	1999 (Cycle 8)	$423,216
University of California, Santa Barbara	Pulmonary Disease

Apolipoprotein E: remnant metabolism and atherogenesis	1999 (Cycle 8)	$793,474
J. David Gladstone Institutes	Cardiovascular Disease

Family factors in smoking acquisition among Latino youth	1998 (Cycle 7)	$865,636
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Oxidative damage to sperm DNA: smoking and diet interaction	1998 (Cycle 7)	$155,135
University of California, Berkeley	General Biomedical Science

Antioxidants, cigarette smoking and atherosclerosis	1998 (Cycle 7)	$730,640
University of Southern California	Epidemiology

Mechanisms underlying diaphragm adaptations in emphysema	1998 (Cycle 7)	$642,624
Cedars-Sinai Medical Center	Pulmonary Disease

Suppressor genes of lung cancer	1998 (Cycle 7)	$859,254
The Burnham Institute for Medical Research	Cancer

How does smoke activate mucin transcription in lung cells?	1998 (Cycle 7)	$432,415
University of California, San Francisco	Pulmonary Disease

Smoking treatment for substance abusing adolescents	1998 (Cycle 7)	$431,607
University of California, San Diego	Tobacco-Use Prevention and Cessation

Towards gene therapy for tobacco-related vascular disease	1998 (Cycle 7)	$719,328
J. David Gladstone Institutes	Cardiovascular Disease

Mechanisms by which tobacco accelerates atherosclerosis	1998 (Cycle 7)	$675,731
Stanford University	Cardiovascular Disease

Therapy for muscle dysfunction in COPD: cellular adaptations	1998 (Cycle 7)	$502,904
Cedars-Sinai Medical Center	Pulmonary Disease

Behavioral epidemiology of tobacco use among gay men	1998 (Cycle 7)	$626,433
University of California, San Francisco	Epidemiology

Smoking and lifestyle risk factors for premenstrual changes	1998 (Cycle 7)	$297,783
University of California, Davis	Epidemiology

Studies of novel antitumor agents for lung cancers	1998 (Cycle 7)	$306,000
University of California, San Diego	Cancer

Vapor-phase organics in ETS: dynamics and exposure	1998 (Cycle 7)	$722,775
Lawrence Berkeley National Laboratory	General Biomedical Science

Keep me smokefree	1998 (Cycle 7)	$550,002
Education Training and Research Associates, Inc.	Tobacco-Use Prevention and Cessation

Mechanism of stress effects on weight in nicotine withdrawal	1998 (Cycle 7)	$407,019
University of California, San Francisco	Nicotine Dependence

Spanish/English web site for smoking cessation trials	1998 (Cycle 7)	$450,400
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Smoke-free bars: analysis of the response from Long Beach	1998 (Cycle 7)	$552,978
California State University, Long Beach Foundation	Public Health, Public Policy, and Economics

Developing new vaccines for lung cancer	1998 (Cycle 7)	$398,511
University of California, Los Angeles	Cancer

Nitrogen Oxides and cigarette smoke-induced injury	1998 (Cycle 7)	$304,118
University of California, Davis	Pulmonary Disease

Bupropion for smoking cessation	1998 (Cycle 7)	$471,154
University of California, San Francisco	Nicotine Dependence

Vitamin E kinetics in smokers	1998 (Cycle 7)	$332,110
University of California, Davis	General Biomedical Science

Transport and disposition of nicotine in the human placenta	1998 (Cycle 7)	$333,108
University of California, San Francisco	General Biomedical Science

Role of thioredoxin in ETS-induced pulmonary airway injury	1998 (Cycle 7)	$425,665
University of California, Davis	Pulmonary Disease

The effect of tobacco smoke on immune function in twins	1998 (Cycle 7)	$822,641
University of Southern California	Epidemiology

Role of nicotine/nicotinic receptors in Parkinson's disease	1998 (Cycle 7)	$644,770
The Parkinson's Institute	Nicotine Dependence

Effects of tobacco smoke exposure on hormones and fertility	1998 (Cycle 7)	$115,335
Sequoia Foundation	Epidemiology

Effects of nicotine on postinfarction cardiac remodeling	1998 (Cycle 7)	$459,799
University of California, San Diego	Cardiovascular Disease

Will apoE cause regression of atherosclerotic lesions?	1998 (Cycle 7)	$165,299
J. David Gladstone Institutes	Cardiovascular Disease

Clinical pharmacology of tobacco alkaloids	1998 (Cycle 7)	$439,882
University of California, San Francisco	Nicotine Dependence

Hormone replacement therapy, smoking & lipoprotein oxidation	1998 (Cycle 7)	$245,584
La Jolla Institute for Molecular Medicine	Cardiovascular Disease

Inflammatory compounds:role in tobacco-related lung disease	1998 (Cycle 7)	$447,367
University of California, San Diego	Cancer

Maternal DNA repair of tobacco-induced sperm lesions	1998 (Cycle 7)	$1,046,880
Lawrence Livermore National Laboratory	General Biomedical Science

Genetic susceptibility to tobacco-induced lung cancer	1998 (Cycle 7)	$406,120
University of California, Los Angeles	Cancer

Effect of tobacco smoke on leukocyte adhesion in vivo	1998 (Cycle 7)	$754,361
La Jolla Institute for Molecular Medicine	Pulmonary Disease

Programmed cell death in cigarette-induced lung disease	1998 (Cycle 7)	$371,556
University of California, San Francisco	Pulmonary Disease

Implementation of California AB 13: smoking ban in bars	1998 (Cycle 7)	$315,181
University of California, San Francisco	Public Health, Public Policy, and Economics

Carbon monoxide and the brain growth spurt	1998 (Cycle 7)	$464,268
University of California, Los Angeles	General Biomedical Science

Tobacco use and cessation among drug users	1998 (Cycle 7)	$249,392
University of California, Los Angeles	Epidemiology

Lipoprotein classes and susceptibility to atherosclerosis	1998 (Cycle 7)	$702,940
J. David Gladstone Institutes	Cardiovascular Disease

Reducing provision of tobacco to minors from social sources	1998 (Cycle 7)	$639,838
Stanford University	Tobacco-Use Prevention and Cessation

Determining how cholesterol-rich Lp(a) causes heart disease	1998 (Cycle 7)	$797,092
J. David Gladstone Institutes	Cardiovascular Disease

ETS exposures in the California Teachers Study cohort	1998 (Cycle 7)	$449,677
Public Health Institute	Epidemiology

Effect of tobacco smoke on lung airway surface liquid	1998 (Cycle 7)	$115,658
Children's Hospital Oakland Research Institute	Pulmonary Disease

Oxidative damage to sperm DNA: smoking and diet interaction	1998 (Cycle 7)	$132,367
Children's Hospital Oakland Research Institute	General Biomedical Science

ETS Effects on airway development in the primate lung	1998 (Cycle 7)	$483,652
University of California, Davis	General Biomedical Science

Role of passive smoke on sperm, ICSI and IVF	1998 (Cycle 7)	$628,862
University of California, San Diego	Epidemiology

Effects of environmental tobacco smoke on pulmonary allergy	1998 (Cycle 7)	$282,568
University of California, Davis	Pulmonary Disease

Neurobiological substrates of nicotine addiction	1998 (Cycle 7)	$742,393
Scripps Research Institute	Nicotine Dependence

Hormone replacement therapy, smoking & lipoprotein oxidation	1998 (Cycle 7)	$385,808
Scripps Research Institute	Cardiovascular Disease

Effects of Selegiline on craving for nicotine	1998 (Cycle 7)	$100,450
Stanford University	Nicotine Dependence

Effects of environmental tobacco smoke on the artery wall	1998 (Cycle 7)	$449,673
University of California, Davis	Cardiovascular Disease

An athletic trainer mediated spit tobacco cessation program	1998 (Cycle 7)	$490,546
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Natural history of tobacco addiction in adolescents	1998 (Cycle 7)	$499,505
University of California, San Francisco	Tobacco-Use Prevention and Cessation

NRT and paroxetine for smoking cessation	1997 (Cycle 6)	$646,916
Stanford University	Nicotine Dependence

Tobacco-related disease in native California twins	1997 (Cycle 6)	$889,746
University of Southern California	Epidemiology

Developing treatments that lower blood cholesterol levels	1997 (Cycle 6)	$746,536
Scripps Research Institute	Cardiovascular Disease

Indoor measurements of environmental tobacco smoke	1997 (Cycle 6)	$634,217
Lawrence Berkeley National Laboratory	General Biomedical Science

ETS effects on pulmonary breathing patterns	1997 (Cycle 6)	$446,954
University of California, Davis	Pulmonary Disease

The role of media in smoking initiation and cessation	1997 (Cycle 6)	$433,880
University of California, San Diego	Epidemiology

Preventing tobacco smoke diseases by network antioxidants	1997 (Cycle 6)	$388,714
University of California, Berkeley	General Biomedical Science

Tobacco-related cancer prevention by Vitamin A derivatives	1997 (Cycle 6)	$149,947
Molecular Medicine Research Institute	Cancer

School tobacco program and policy trial	1997 (Cycle 6)	$1,162,877
University of Southern California	Tobacco-Use Prevention and Cessation

Lung volume reduction surgery in an emphysema model	1997 (Cycle 6)	$404,139
University of California, Irvine	Pulmonary Disease

Environmental tobacco smoke and early atherosclerosis	1997 (Cycle 6)	$383,814
University of Southern California	Epidemiology

Cigar smoking among young adults: formative research	1997 (Cycle 6)	$292,920
California State University, Long Beach Foundation	Tobacco-Use Prevention and Cessation

Gene therapy for emphysema	1997 (Cycle 6)	$443,179
University of California, San Francisco	Pulmonary Disease

Serum cotinine levels and reproductive outcomes	1997 (Cycle 6)	$452,159
Public Health Institute	Epidemiology

Reducing minors' access to tobacco: project CHALK	1997 (Cycle 6)	$398,114
Public Health Foundation Enterprises, Inc.	Tobacco-Use Prevention and Cessation

Pediatrician training to prevent children's tobacco exposure	1997 (Cycle 6)	$133,852
University of California, San Francisco	Public Health, Public Policy, and Economics

Nicotonic receptors: role in addiction and reproduction	1997 (Cycle 6)	$437,480
Salk Institute for Biological Studies	Nicotine Dependence

Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing	1997 (Cycle 6)	$446,947
University of California, Los Angeles	Tobacco-Use Prevention and Cessation

How does cigarette smoke induce cancer?	1997 (Cycle 6)	$811,518
Beckman Research Institute of the City of Hope	Cancer

Fertility, smoking and early mammalian development	1997 (Cycle 6)	$452,243
University of California, Riverside	General Biomedical Science

Environmental tobacco smoke and newborn lung development	1997 (Cycle 6)	$440,500
University of California, Davis	General Biomedical Science

Developing policy to reverse cigar trend: roles of media	1997 (Cycle 6)	$249,785
University of California, San Francisco	Public Health, Public Policy, and Economics

Effect of maternal smoking on human placental development	1997 (Cycle 6)	$450,000
University of California, San Francisco	General Biomedical Science

Nicotine and cardiac vulnerability to fibrillation	1997 (Cycle 6)	$370,057
Cedars-Sinai Medical Center	Cardiovascular Disease

Patterns of tobacco use from adolescence to young adulthood	1997 (Cycle 6)	$565,277
RAND Corporation	Epidemiology

Cigarette smoke alters lipoprotein & artery wall interaction	1997 (Cycle 6)	$472,876
University of California, Los Angeles	Cardiovascular Disease

Tobacco-related cancer prevention by Vitamin A derivatives	1997 (Cycle 6)	$274,488
SRI International	Cancer

Motivation-enhanced teenage tobacco use cessation	1997 (Cycle 6)	$750,248
University of Southern California	Tobacco-Use Prevention and Cessation

Nicotine pharmacogenetics: influence of ethnicity	1997 (Cycle 6)	$242,344
Cedars-Sinai Medical Center	Nicotine Dependence

Aggression and Nicotine	1997 (Cycle 6)	$230,826
University of California, Irvine	Nicotine Dependence

Recruitment of leukocytes to atherosclerotic lesions in vivo	1997 (Cycle 6)	$352,405
University of California, San Diego	Cardiovascular Disease

The role of multiple genes in susceptibility to smoking	1997 (Cycle 6)	$557,829
Beckman Research Institute of the City of Hope	Epidemiology

Brain adaptations to chronic nicotine expsoure	1997 (Cycle 6)	$402,111
University of California, Irvine	Nicotine Dependence

Spanish tobacco-related disease self-management: evaluation	1997 (Cycle 6)	$693,751
Stanford University	Tobacco-Use Prevention and Cessation

Novel imaging methods for diagnosing tobacco related cancers	1997 (Cycle 6)	$629,087
Stanford University	Cancer

Nicotine pharmacogenetics: influence of ethnicity	1997 (Cycle 6)	$366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Nicotine Dependence

Brachial Vasoreactivity in Young Adult Smokers	1997 (Cycle 6)	$332,294
Osteoporosis Medical Center	Epidemiology

Smoking initiation among Chinese and Vietnames adolescents	1997 (Cycle 6)	$449,734
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Hyperactive nicotine receptors	1997 (Cycle 6)	$486,158
California Institute of Technology	Nicotine Dependence

Oral clefts, smoking & variation toxin biotransformation	1997 (Cycle 6)	$677,128
Children's Hospital Oakland Research Institute	Epidemiology

Evaluation of ad strategies for preventing youth tobacco use	1997 (Cycle 6)	$136,953
University of California, Irvine	Public Health, Public Policy, and Economics

Secondhand smoke promotes chemical toxicity in fetal lung	1997 (Cycle 6)	$190,536
University of California, Davis	General Biomedical Science

Case studies of indoor air regulations: role of research	1997 (Cycle 6)	$292,210
University of California, San Francisco	Public Health, Public Policy, and Economics

Novel therapy for pancreatic cancer	1997 (Cycle 6)	$452,332
University of California, Irvine	Cancer

Cardiovascular responses to nicotine	1997 (Cycle 6)	$430,843
University of California, San Diego	Nicotine Dependence

Irritant and pain-reducing effects of nicotine	1997 (Cycle 6)	$415,704
University of California, Davis	Nicotine Dependence

Transdermal nicotine replacement for hospitalized smokers	1997 (Cycle 6)	$451,969
University of California, San Francisco	Nicotine Dependence

Smokeless tobacco cessation among lumber mill employees	1997 (Cycle 6)	$620,213
University of Southern California	Tobacco-Use Prevention and Cessation

Does nicotine inhibit anticancer activities of Vitamin A?	1997 (Cycle 6)	$788,808
The Burnham Institute for Medical Research	Cancer

Diaphragm adaptations following treatment for emphysema	1997 (Cycle 6)	$469,400
Cedars-Sinai Medical Center	Pulmonary Disease

Development of a blood test for pancreatic cancer	1997 (Cycle 6)	$308,819
Stanford University	Cancer

Quantification of population exposure to secondhand smoke	1997 (Cycle 6)	$686,858
Stanford University	Epidemiology

Smoking predictors in Mexican American youth	1997 (Cycle 6)	$534,603
University of San Francisco	Tobacco-Use Prevention and Cessation

The role of nicotine receptors in nicotine dependence	1997 (Cycle 6)	$381,317
University of California, Irvine	Nicotine Dependence

Improving tobacco use assessment among youth via telephone	1997 (Cycle 6)	$347,440
University of California, Berkeley	Public Health, Public Policy, and Economics

Quantification of lung doses from inhaled tobacco smoke	1997 (Cycle 6)	$425,728
University of California, Irvine	General Biomedical Science

Nicotine toxicity acting on cardiac neurons	1997 (Cycle 6)	$446,920
University of California, San Diego	Nicotine Dependence

Therapies of muscle dysfunction in obstructive lung disease	1997 (Cycle 6)	$659,714
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Pulmonary Disease

Suppression of Oncogenic Ras Mutations	1995 (Cycle 4)	$348,032
University of California, Berkeley	Cancer

Role of Ah Receptor Nuclear Translocator in Carcinogenesis	1995 (Cycle 4)	$140,096
University of California, Los Angeles	Cancer

A Methodological Multi-Ethnic Study of Smoking Initiation	1995 (Cycle 4)	$260,978
University of California, Los Angeles	Tobacco-Use Prevention and Cessation

Detrimental Influence of Nitric Oxide on Vascular Function	1995 (Cycle 4)	$8,965
University of California, Los Angeles	Cardiovascular Disease

Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke	1995 (Cycle 4)	$454,365
Lawrence Berkeley National Laboratory	Cardiovascular Disease

Membrane Signaling Pathways of RAS/RAB Proteins	1995 (Cycle 4)	$574,559
Scripps Research Institute	Cancer

Identification on Tumors of Molecular Targets for NK Cells	1995 (Cycle 4)	$314,006
University of California, San Francisco	Cancer

Effect of Tobacco on Rat Lung Alveolar Lining Liquid	1995 (Cycle 4)	$643,213
Lawrence Berkeley National Laboratory	Pulmonary Disease

Vasoactive Mediators of Fetal Growth Retardation	1995 (Cycle 4)	$615,296
Cedars-Sinai Medical Center	Epidemiology

Smoking Cessation in Vietnamese: A Controlled Trial	1995 (Cycle 4)	$429,006
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Fertility, Smoking, and Early Mammalian Development	1995 (Cycle 4)	$321,193
University of California, Riverside	General Biomedical Science

Inheritance and Smoking in Urinary Tract & Pancreas Cancer	1995 (Cycle 4)	$248,283
University of Southern California	Epidemiology

Determinants of Susceptibility to Oxidized Lipoproteins	1995 (Cycle 4)	$495,384
University of California, Los Angeles	Cardiovascular Disease

Expression of the Human apo-B Gene in Transgenic Mice	1995 (Cycle 4)	$211,090
J. David Gladstone Institutes	Cardiovascular Disease

Smoking, Free Radicals, Antioxidants and Disease Prevention	1995 (Cycle 4)	$408,853
University of California, Berkeley	Pulmonary Disease

Passive Smoking: Role of Airways Reactivity in Infancy	1995 (Cycle 4)	$486,888
University of California, Berkeley	Epidemiology

Clinical Pharmacology of Tobacco Alkaloids	1995 (Cycle 4)	$393,855
University of California, San Francisco	General Biomedical Science

Electrophysiological Effects of Perinatal Nicotine Exposure	1995 (Cycle 4)	$293,752
San Diego State University Research Foundation	General Biomedical Science

Tumor-Specific Vascular Proteins in Lung Cancer	1995 (Cycle 4)	$105,294
University of California, San Diego	Cancer

Proteins that Remove Atherogeneic Lipoproteins from Blood	1995 (Cycle 4)	$678,254
J. David Gladstone Institutes	Cardiovascular Disease

Reduction of Passive Smoking in Asthmatic Children	1995 (Cycle 4)	$282,971
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Function and Regulation of the Retinoblastoma Protein	1995 (Cycle 4)	$385,031
University of California, San Diego	Cancer

Calorigenic and Atherogenic Effects of Smoking and Nicotine	1995 (Cycle 4)	$357,492
University of California, San Francisco	Cardiovascular Disease

Quality of Tobacco Industry Funded Research	1995 (Cycle 4)	$152,885
University of California, San Francisco	Public Health, Public Policy, and Economics

Passive Smoking and Clara Cell Development in the Lungs	1995 (Cycle 4)	$442,317
University of California, Davis	Pulmonary Disease

Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure	1995 (Cycle 4)	$746,727
SRI International	Cardiovascular Disease

NMR Study of 13C Edatrexate Metabolism	1995 (Cycle 4)	$258,990
University of California, Davis	Cancer

The Dopamine D2 Receptor in Nicotine Addiction	1995 (Cycle 4)	$304,790
City of Hope National Medical Center	General Biomedical Science

Predicting and Reducing Cigarette Sales to Minors	1995 (Cycle 4)	$350,549
Public Health Foundation Enterprises, Inc.	Public Health, Public Policy, and Economics

Control of Mucociliary Clearance in the Respiratory Tract	1995 (Cycle 4)	$276,780
University of California, Los Angeles	Pulmonary Disease

Interactions of Moesin during platelet activation	1995 (Cycle 4)	$428,524
Stanford University	Cardiovascular Disease

Cellular Defects in Lung caused by Tobacco Smoke	1995 (Cycle 4)	$319,013
University of California, San Francisco	Pulmonary Disease

Smoking, Nicotine, Sleep & Mood in Normals & Depression	1995 (Cycle 4)	$207,434
University of California, San Diego	Tobacco-Use Prevention and Cessation

Effect of Smoking on Success Rate of In Vitro Fertilization	1995 (Cycle 4)	$449,805
University of California, San Diego	Epidemiology

Expressing & Cloning of ATP-Sensitive Potassium Channels	1995 (Cycle 4)	$286,163
University of California, Santa Barbara	Cardiovascular Disease

Structure-Function Correlations for Ras p21 and its Mutants	1995 (Cycle 4)	$322,049
University of Southern California	Cancer

Electrophysiological Effects of Perinatal Nicotine Exposure	1995 (Cycle 4)	$446,225
Scripps Research Institute	General Biomedical Science

H-Ras Ribozyme Mediated Tumor Suppression of BUX Cells	1995 (Cycle 4)	$352,183
City of Hope National Medical Center	Cancer

Developmental Relationship between NK and T-Cell Lineages	1995 (Cycle 4)	$434,126
California Institute of Technology	Cancer

Cardiac Arrythmias Before and After Smoking Cessation	1995 (Cycle 4)	$93,780
University of California, San Francisco	Cardiovascular Disease

Smoking, Personality and the Risk of Parkinson's Disease	1995 (Cycle 4)	$297,245
Kaiser Foundation Research Institute	Epidemiology

SAR Studies of Novel antitumor Agents for Lung Carcinomas	1995 (Cycle 4)	$403,338
University of California, San Diego	Cancer

Effects of Tobacco Smoke on Mucin Production in Rat Airways	1995 (Cycle 4)	$356,400
University of California, San Francisco	Pulmonary Disease

Nicotine and Smoking Effects on Neuromuscular Development	1995 (Cycle 4)	$412,639
Cedars-Sinai Medical Center	Pulmonary Disease

Gene Markers for Hypertension	1995 (Cycle 4)	$356,151
University of California, San Francisco	Cardiovascular Disease

Ad and Movie Imagery and Teen's Perceptions About Smokers	1995 (Cycle 4)	$190,616
University of California, Irvine	Public Health, Public Policy, and Economics

Predicting and Reducing Cigarette Sales to Minors	1995 (Cycle 4)	$358,643
University of Southern California	Public Health, Public Policy, and Economics

Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro	1995 (Cycle 4)	$321,199
University of California, San Diego	Cancer

Expression of the Human apo-B Gene in Transgenic Mice	1995 (Cycle 4)	$569,759
Palo Alto Medical Foundation Research Institute	Cardiovascular Disease

A Smokeless Tobacco Cessation Program: High School Athletes	1995 (Cycle 4)	$533,923
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Effects of Environmental Tobacco Smoke on Pulmonary Allergy	1995 (Cycle 4)	$256,805
University of California, Davis	Pulmonary Disease

Transcriptional Regulation of Programmed Cell Dealth	1995 (Cycle 4)	$304,418
University of California, Berkeley	Cancer

Heterologous Expression of Brain Nicotinic Acetylcholine Receptor	1995 (Cycle 4)	$598,774
California Institute of Technology	Nicotine Dependence

Smoking and Arterial Flux of Low Density Lipoprotein	1994 (Cycle 3)	$274,674
University of California, Davis	Cardiovascular Disease

T-Cell Stimulating Antigen Genes in Tumor Cells	1994 (Cycle 3)	$362,814
University of California, Berkeley	Cancer

Regulation of Natural Killer Cell Activity by Theophylline	1994 (Cycle 3)	$172,231
University of California, Los Angeles	Pulmonary Disease

Hormones and Tobacco: Joint Effects on Reproduction	1994 (Cycle 3)	$263,611
Public Health Institute	Epidemiology

Functional Synthetic Peptide Mimics of Apolipoprotein E	1994 (Cycle 3)	$653,578
Scripps Research Institute	Cardiovascular Disease

Desensitization of Cholinergic Mechanisms & Nicotine Addiction	1994 (Cycle 3)	$267,178
University of California, Davis	Nicotine Dependence

Oral Clefts, Candidate Genes, & Parental Tobacco Use	1994 (Cycle 3)	$253,154
March of Dimes Birth Defects Foundation	Epidemiology

Diagnosis and Treatment of MTAse-Deficient Lung Cancers	1994 (Cycle 3)	$370,631
University of California, San Diego	Cancer

Modeling US Lung Cancer Death Rates	1994 (Cycle 3)	$158,756
University of California, San Diego	Epidemiology

Role of aV Integrins in Malignancy of Tobacco/Induced Tumors	1994 (Cycle 3)	$485,909
Scripps Research Institute	Cancer

Smokeless Tobacco Cessation Among Lumber Mill Employees	1994 (Cycle 3)	$159,203
University of Southern California	Tobacco-Use Prevention and Cessation

Role of the Acetyl LDL Receptor in Atherogenesis	1994 (Cycle 3)	$121,187
J. David Gladstone Institutes	Cardiovascular Disease

Correlates of Smoking in Teen, Adult & Pregnant Women in CA	1994 (Cycle 3)	$136,082
University of California, San Francisco	Public Health, Public Policy, and Economics

D2 Dopamine Receptor Alleles in Smokers & Nonsmokers	1994 (Cycle 3)	$356,559
University of California, Los Angeles	Public Health, Public Policy, and Economics

Cell Adhesion Receptors in Atherogenesis	1994 (Cycle 3)	$391,252
Scripps Research Institute	Cardiovascular Disease

Environmental Tobacco Smoke and Lung Cancer	1994 (Cycle 3)	$234,432
University of California, Davis	Cancer

Role of Nitric Oxide in Smoking-Related Vascular Impotence	1994 (Cycle 3)	$531,486
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Cardiovascular Disease

Periodic Gene Expression in the G1 Phase of the Cell Cycle	1994 (Cycle 3)	$498,844
California Institute of Technology	Cancer

Weight Gain as a Predictor of Smoking Relapse	1994 (Cycle 3)	$750,320
SRI International	Tobacco-Use Prevention and Cessation

Acetylcholine Receptors in the Developing Nervous System	1994 (Cycle 3)	$116,263
University of California, San Diego	Nicotine Dependence

Smoking and Risk of Proximal Vs. Distal Gastric Cancer	1994 (Cycle 3)	$835,887
University of Southern California	Epidemiology

Nicotine & Cocaine Dynamics: Patterns & Consequences	1994 (Cycle 3)	$277,738
University of California, Los Angeles	Public Health, Public Policy, and Economics

Na/H Exchange in Hypoxic/Ischemic Myocardium: Effects on Ca	1994 (Cycle 3)	$243,322
University of California, Davis	Cardiovascular Disease

Tobacco Prevention for Hard to Reach Youth	1994 (Cycle 3)	$224,497
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Pathogenesis of Smoke-Induced Injury in Airway Epithelium	1994 (Cycle 3)	$431,266
University of California, Davis	Pulmonary Disease

Environmental Tobacco Smoke and Fetal Growth Retardation	1994 (Cycle 3)	$124,865
University of California, Davis	General Biomedical Science

Signal Transduction and Cell Activation	1994 (Cycle 3)	$404,312
Salk Institute for Biological Studies	Cancer

Monocyte Chemoattractant Protein (MCP-1) in Atherosclerosis	1994 (Cycle 3)	$484,207
J. David Gladstone Institutes	Cardiovascular Disease

Smoking Cessation After Surgery/A Randomized Trial	1994 (Cycle 3)	$378,222
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Response of Respiratory Cancers to Novel Antiofolates	1994 (Cycle 3)	$175,926
University of Southern California	Cancer

The Character, Costs, and Impacts of Public Smoking Programs	1994 (Cycle 3)	$137,264
University of California, Berkeley	Public Health, Public Policy, and Economics

Radioimmunotherapy of Lung Cancer	1994 (Cycle 3)	$318,994
University of Southern California	Cancer

Effects of Nicotine on Weight	1994 (Cycle 3)	$136,752
Stanford University	General Biomedical Science

Role of Protein Phosphatase 2A in Lung Carcinoma	1994 (Cycle 3)	$342,144
University of California, San Diego	Cancer

Sidestream Tobacco Smoke Dispersion and Inhalability	1994 (Cycle 3)	$265,856
University of California, Irvine	General Biomedical Science

Sites of Chemoattractant Receptor Interaction with G Protein	1994 (Cycle 3)	$720,174
Scripps Research Institute	Pulmonary Disease

Integrin Cytoplasmic Domains and Ligand Affinity Modulation	1994 (Cycle 3)	$522,649
Scripps Research Institute	Cardiovascular Disease

Smoking Related Abnormalities of the Lung Surfactant System	1994 (Cycle 3)	$438,278
University of California, San Diego	Pulmonary Disease

Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma	1994 (Cycle 3)	$389,719
University of California, San Francisco	Cancer

Effects of Tobacco Smoke on Proto-Oncogene Activity	1994 (Cycle 3)	$382,758
University of California, San Diego	Cancer

Mechanism of Mitotic Chromosome Condensation	1994 (Cycle 3)	$292,842
University of California, San Francisco	Cancer

Regulation of GP IIb-IIIa by the Platelet Cytoskeleton	1994 (Cycle 3)	$537,597
Children's Hospital Oakland Research Institute	Cardiovascular Disease

Tobacco Smoking & Genetic Alterations in Bladder Epithelium	1994 (Cycle 3)	$282,853
University of California, San Francisco	Cancer

Genetic Markers of Lung Cancer Risk Among Blacks & Whites	1994 (Cycle 3)	$295,028
University of Southern California	Epidemiology

Role of Annexins in Neutrophil Degranulation	1994 (Cycle 3)	$422,822
University of California, San Francisco	Pulmonary Disease

Smoking and HDL Cholesterol in Minority Youth	1994 (Cycle 3)	$669,343
University of Southern California	Epidemiology

Radioimmunotherapy & Hypoxic Cytotoxin in Squamous Cancer	1994 (Cycle 3)	$157,321
SRI International	Cancer

The Dopamine D2 Receptor in Nicotine Addiction	1994 (Cycle 3)	$162,870
City of Hope National Medical Center	Nicotine Dependence

Effect of Maternal Smoking on Human Placental Development	1994 (Cycle 3)	$406,527
University of California, San Francisco	General Biomedical Science

Mechanisms Underlying Smoking-Induced Oxidation of LDL	1994 (Cycle 3)	$264,586
University of California, San Diego	Cardiovascular Disease

Cell Adhesion Receptors in Atherogenesis	1994 (Cycle 3)	$170,341
The Burnham Institute for Medical Research	Cardiovascular Disease

Autocrine Interactions Between Bombesin and its Receptor	1994 (Cycle 3)	$316,238
University of California, San Diego	Cancer

Defensins and à2-macroglobulin in Lung Inflammation	1994 (Cycle 3)	$316,269
University of California, Los Angeles	Pulmonary Disease

Tobacco Smoke Exposure & Chromosomally Defective Sperm	1994 (Cycle 3)	$438,464
Lawrence Livermore National Laboratory	Epidemiology

Cloning & Expression of the Apo-B mRNA Editing Factor	1994 (Cycle 3)	$254,743
J. David Gladstone Institutes	Cardiovascular Disease

Phosphoryl Peptide Inhibitors of Tyrosine Kinases	1993 (Cycle 2)	$308,697
University of California, San Francisco	Cancer

Oral Cancer: Adhesive Interactions During Progression	1993 (Cycle 2)	$182,765
University of California, San Francisco	Cancer

Advances in Lung Cancer Detection with Digital Techniques	1993 (Cycle 2)	$276,730
University of California, Los Angeles	Cancer

Tobacco Smoke and Airway Fluid Transport & Composition	1993 (Cycle 2)	$301,622
University of California, Riverside	Pulmonary Disease

Nicotine, Tobacco Smoke and the Blood-Brain Barrier	1993 (Cycle 2)	$624,017
University of Southern California	Nicotine Dependence

Measurement & Outcomes of Dyspnea in COPD	1993 (Cycle 2)	$193,253
University of California, San Diego	Pulmonary Disease

Control of breathing in infants of smoking mothers	1993 (Cycle 2)	$290,986
California Pacific Medical Center Research Institute	Epidemiology

Steroid Influences on Diaphragm Performance in Emphysema	1993 (Cycle 2)	$343,914
Cedars-Sinai Medical Center	Pulmonary Disease

Asymmetric Synthesis of (-)-Podophyllotoxin	1993 (Cycle 2)	$121,946
University of California, Santa Cruz	Cancer

The Cost of Passive Smoking on Children's Health	1993 (Cycle 2)	$242,086
RAND Corporation	Public Health, Public Policy, and Economics

Tobacco-Related Disease Trends among 118,000 Californians	1993 (Cycle 2)	$236,471
University of California, Los Angeles	Epidemiology

The Effects of Tobacco Smoke on Airway Mucin mRNA	1993 (Cycle 2)	$71,867
University of California, San Francisco	Pulmonary Disease

Health Related Quality of Life Outcomes of Smokers Who Quit	1993 (Cycle 2)	$338,364
University of California, San Francisco	Public Health, Public Policy, and Economics

Nicotinic Receptors, Tolerance and Spinal Neurotransmitters	1993 (Cycle 2)	$320,869
University of California, San Diego	Nicotine Dependence

Structure-function studies of RAS nucleotide-exchange-factor	1993 (Cycle 2)	$593,460
University of Southern California	Cancer

Nicotine Addiction: Novel ACh Receptors on Neurons	1993 (Cycle 2)	$369,025
University of California, San Diego	Nicotine Dependence

Tobacco Induced Hypoxia: Molecular Genetic Responses	1993 (Cycle 2)	$685,782
University of Southern California	Cardiovascular Disease

Clinician Initiated Smoking Prevention: A Controlled Trial	1993 (Cycle 2)	$2,071,588
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Effect of Cigarette Smoke on Vascular Wall Permeability	1993 (Cycle 2)	$99,854
University of California, Davis	Cardiovascular Disease

Smoke Induced Differntial Expression of Cellular Proteins	1993 (Cycle 2)	$257,010
University of California, San Francisco	Pulmonary Disease

Smoking as a risk factor in the etiology of down syndrome	1993 (Cycle 2)	$730,292
March of Dimes Birth Defects Foundation	Epidemiology

Statistics of Tobacco Smoke Exposure	1993 (Cycle 2)	$910,542
Stanford University	Epidemiology

Sucellular Localization of CAMP-dependent Protein Kinase	1993 (Cycle 2)	$338,472
University of California, San Diego	Cancer

The Effect of Cigarette Smoke on Airway Neuronal Receptors	1993 (Cycle 2)	$225,260
University of California, San Francisco	Pulmonary Disease

Smoking and Leukemia: A Molecular Genetic Approach	1993 (Cycle 2)	$334,253
University of California, Los Angeles	Cancer

Smoking Ordinances, Passive Smoking and Smoking Cessation	1993 (Cycle 2)	$151,547
Molecular Medicine Research Institute	Public Health, Public Policy, and Economics

Radon Attachment to Cigarette Smoke Aerosols	1993 (Cycle 2)	$344,430
Lawrence Livermore National Laboratory	General Biomedical Science

Effect of Single-Session Hypnosis on Smoking Cessation	1993 (Cycle 2)	$610,950
Stanford University	Tobacco-Use Prevention and Cessation

Do Follow-up Visits Help Patients Quit Smoking?	1993 (Cycle 2)	$745,189
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Fertility, Smoking, and Early Mammalian Development	1993 (Cycle 2)	$166,751
University of California, Riverside	General Biomedical Science

Expression of a drug resistance gene in head and neck cancer	1993 (Cycle 2)	$337,086
University of California, San Diego	Cancer

Activated Protein C in Smokers Thrombosis	1993 (Cycle 2)	$347,737
Scripps Research Institute	Cardiovascular Disease

Role of Elastin Peptides in Neutrophil-Mediated Lung Injury	1993 (Cycle 2)	$495,336
Childrens Hospital, Los Angeles	Pulmonary Disease

Angiotensin II and Restenosis after Coronary Angioplasty	1993 (Cycle 2)	$228,018
University of California, Davis	Cardiovascular Disease

Effect of Cigarette Smoke on High Risk Lipoprotein Profiles	1993 (Cycle 2)	$332,996
Lawrence Berkeley National Laboratory	Cardiovascular Disease

Vascular Effects of Nicotine: Effect of Age	1993 (Cycle 2)	$331,124
University of California, Irvine	Nicotine Dependence

Smoking-Induced Impairment of Pulmonary Host Defense	1993 (Cycle 2)	$381,970
University of California, Irvine	Pulmonary Disease

Regulation of Oxidant Production in Activated Phagocytes	1993 (Cycle 2)	$540,379
Scripps Research Institute	Pulmonary Disease

Modeling U.S. Lung Cancer Death Rates	1993 (Cycle 2)	$127,276
University of California, San Diego	Epidemiology

Smoking Cessation in Recovering Alcoholic Person (SCRAP)	1993 (Cycle 2)	$835,924
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Tobacco Product Modulation of TNF Responses in Lung Cells	1993 (Cycle 2)	$371,620
University of California, Riverside	General Biomedical Science

Determinants of Thrombin Interaction With Its Receptor	1993 (Cycle 2)	$264,243
University of California, San Francisco	Cardiovascular Disease

Ethnicity and the Meaning of Smoking in Older Age Groups	1993 (Cycle 2)	$317,076
University of California, San Francisco	Public Health, Public Policy, and Economics

Relating Tobacco Access and Consumption Among Youth	1993 (Cycle 2)	$489,771
Stanford University	Tobacco-Use Prevention and Cessation

Smoking-Related Advertising and Preteens' Social Perceptions	1993 (Cycle 2)	$72,837
University of California, Irvine	Public Health, Public Policy, and Economics

Smoking and Lipoprotein-Based Mechanisms of Atherogenesis	1993 (Cycle 2)	$250,645
University of California, San Francisco	Cardiovascular Disease

Modifiers of susceptibility to smoking for lung cancer	1993 (Cycle 2)	$201,856
University of Southern California	Epidemiology

CNS effects of prenatal nicotine exposure: threshold dosage	1993 (Cycle 2)	$458,763
LA Biomedical Research Institute at Harbor-UCLA Medical Center	Nicotine Dependence

Apolipoprotein(a) and Cardiovascular Disease	1993 (Cycle 2)	$590,733
Stanford University	Cardiovascular Disease

Analysis of Retinoid Mediated Anti-cancer Activities	1993 (Cycle 2)	$757,415
The Burnham Institute for Medical Research	Cancer

The Mechanism of Nicotine-Induced Gastric Mucosal Injury	1992 (Cycle 1)	$221,032
University of California, Los Angeles	General Biomedical Science

CNS Processing of Lung Afferent & Cigarette Smoke Inputs	1992 (Cycle 1)	$261,726
University of California, Davis	Pulmonary Disease

Effects of Social & Personal Coping Programs for Smok Prevention	1992 (Cycle 1)	$676,689
University of Southern California	Tobacco-Use Prevention and Cessation

A Genetic Marker of Lung Cancer Risk Among Blacks & Whites	1992 (Cycle 1)	$1,036,615
University of Southern California	Epidemiology

Environmental Tobacco Smoke & Lung Development	1992 (Cycle 1)	$512,031
University of California, Irvine	Pulmonary Disease

Carotid Body Amplification of Exertional Dyspnea in Smokers	1992 (Cycle 1)	$196,560
University of California, Los Angeles	Pulmonary Disease

Complement Mediated Cardiac Ischemei & Thromboxane Release	1992 (Cycle 1)	$291,601
Veterans Medical Research Foundation	Cardiovascular Disease

Tobacco & Its Releated Diseases: Law, Policy & Politics	1992 (Cycle 1)	$218,932
University of California, Berkeley	Public Health, Public Policy, and Economics

Early Detection of Lung Cancer with Monoclonal Antibodies	1992 (Cycle 1)	$860,784
University of California, Los Angeles	Cancer

Cloning of Two Genes Involved it Tobacco Carcinogenesis	1992 (Cycle 1)	$323,634
University of California, Los Angeles	Cancer

Tobacco Carcinogens/C-Kinase Oxidative Activation/Metastasis	1992 (Cycle 1)	$363,557
University of Southern California	Cancer

Smoking Effects on Maternal Folate & Reproductive Outcomes	1992 (Cycle 1)	$105,988
University of California, Davis	Epidemiology

Black-White Differences in Menthol Cigarette Smoking	1992 (Cycle 1)	$332,764
University of California, Los Angeles	Public Health, Public Policy, and Economics

Determinants of Maximum Oxygen Transport.	1992 (Cycle 1)	$282,699
University of California, San Diego	Pulmonary Disease

Lung Cancer: p53 as a Paradigm of Tumor Suppression	1992 (Cycle 1)	$327,795
University of California, Los Angeles	Cancer

Hospital-Based Intervention to Prevent Smoking Relapse	1992 (Cycle 1)	$676,939
Stanford University	Tobacco-Use Prevention and Cessation

Protection of Lung Epithelium by Heat Shock Proteins	1992 (Cycle 1)	$357,085
University of California, Irvine	Pulmonary Disease

Heterologous Expression of Brain Nicotinic Receptors	1992 (Cycle 1)	$586,840
California Institute of Technology	Nicotine Dependence

Role of Smoking in Progression of Anal Neoplasia	1992 (Cycle 1)	$638,812
University of California, San Francisco	Epidemiology

Smoking & Adverse Reproductive Health Effects in Women	1992 (Cycle 1)	$550,243
University of California, Davis	Epidemiology

Smoking & Atherosclerosis--An Autoimmune Phenomenon?	1992 (Cycle 1)	$151,149
University of California, Davis	Cardiovascular Disease

Significance of Immune Complexes in Human Lung Carcinoma	1992 (Cycle 1)	$111,083
University of California, Los Angeles	Pulmonary Disease

Stress & Smoking in Natural Settings: An Ambulatory Study	1992 (Cycle 1)	$489,853
University of California, Los Angeles	Public Health, Public Policy, and Economics

Effects of Sedatives on Neuronal Nicotinic Binding	1992 (Cycle 1)	$394,301
University of California, San Francisco	Nicotine Dependence

Risks for Selected Birth Defects from Parental Cig Smoke	1992 (Cycle 1)	$560,383
March of Dimes Birth Defects Foundation	Epidemiology

A Smokeless Tobacco Cessation Intervention: College Athletes	1992 (Cycle 1)	$648,997
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Control of Mucociliary Clearance in the Respiratory Tract	1992 (Cycle 1)	$404,950
University of California, Los Angeles	Pulmonary Disease

The Accumbens: A Critical Brain Site for Nicotine Craving	1992 (Cycle 1)	$532,964
Scripps Research Institute	Nicotine Dependence

Involvement of the Tumor Suppressor Gene p53 in Lung Cancer	1992 (Cycle 1)	$112,504
University of California, Irvine	Cancer

Smoking-Induced Mod. of Resp. Burst Oxidase of Human Phagocy	1992 (Cycle 1)	$298,435
University of California, San Diego	Pulmonary Disease

Differentiating Preadolescent/Adolescent Paths to Smoking	1992 (Cycle 1)	$459,986
University of Southern California	Public Health, Public Policy, and Economics

Vietnamese Smoking Cessation Intervention: A Controlled Trial	1992 (Cycle 1)	$707,559
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Clinical Pharmacology of Tobacco Alkaloids	1992 (Cycle 1)	$538,143
University of California, San Francisco	Public Health, Public Policy, and Economics

Integrin Distribution & Function in Lung Carcinoma Cells	1992 (Cycle 1)	$358,128
University of California, San Francisco	Cancer

Effects of Smoking on Metabolism During Rest & Exercise	1992 (Cycle 1)	$504,382
University of California, Berkeley	Pulmonary Disease

Effects of Tobacco on Rat Lung Alveolar Lining Liquid	1992 (Cycle 1)	$417,585
Lawrence Berkeley National Laboratory	Pulmonary Disease

Amnesty Smoking Prevention Project	1992 (Cycle 1)	$686,087
University of Southern California	Tobacco-Use Prevention and Cessation

Suppression of Oncogenic RAS Mutations	1992 (Cycle 1)	$355,159
University of California, Berkeley	Cancer

Adenosine Airway Reactivity & Receptors in Smokers	1992 (Cycle 1)	$93,500
University of California, Davis	Pulmonary Disease

Interaction of Complement C4b-Binding Protein with Protein B	1992 (Cycle 1)	$616,016
Scripps Research Institute	General Biomedical Science

Passive Smoking & Clara Cell Developement in the Lungs	1992 (Cycle 1)	$435,023
University of California, Davis	Pulmonary Disease

Impact of Caffeine Use On Tobacco Cessation & Withdrawal	1992 (Cycle 1)	$377,968
Loma Linda University	Tobacco-Use Prevention and Cessation

Interaction of Occupational Aerosols & Tobacco Smoke	1992 (Cycle 1)	$192,878
University of California, Los Angeles	General Biomedical Science

Factors Required for K-RAS 4B Membrane Association/Activity	1992 (Cycle 1)	$600,414
Scripps Research Institute	General Biomedical Science

Environmental & Genetic Risk Factors for Bladder Cancer	1992 (Cycle 1)	$1,147,940
University of Southern California	Epidemiology

Tobacco Industry Response to Passive Smoking	1992 (Cycle 1)	$484,233
University of California, San Francisco	Public Health, Public Policy, and Economics

Effects of Nicotine on Human Information Processing	1992 (Cycle 1)	$247,818
Northern California Institute for Research & Education	Public Health, Public Policy, and Economics

Laryngeal Cancer Risk Factors: Tobacco Interactions	1992 (Cycle 1)	$720,644
Public Health Institute	Epidemiology

An Endogenous Lectin in Airway Epithelium & Lung Cancer	1992 (Cycle 1)	$463,703
University of California, San Francisco	Pulmonary Disease

Roles of Hypoxia, Nicotine & cAMP in Ischemic Heart Failure	1992 (Cycle 1)	$713,367
SRI International	Cardiovascular Disease

Reduction of Passive Smoking in Asthmatic Children: Clinical	1992 (Cycle 1)	$521,489
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Optim. of Train. in Patients w/Chronic Obstruc. Pulm Disease	1992 (Cycle 1)	$467,503
Cedars-Sinai Medical Center	Pulmonary Disease

Prospective Study of Cigarette Smoking & Behavior Dysfunction	1992 (Cycle 1)	$500,370
University of California, Berkeley	Public Health, Public Policy, and Economics

Pathways for Reverse Cholesterol Transport	1992 (Cycle 1)	$265,990
University of California, San Diego	Cardiovascular Disease

Smoking & Passive Smoking Patterns in Chinese Americans	1992 (Cycle 1)	$524,884
Public Health Institute	Epidemiology

Novel Approach to Head & Neck Cancer Therapy	1992 (Cycle 1)	$384,743
University of Southern California	Cancer

Tumor Suppressor Genes in Human Lung Cancer	1992 (Cycle 1)	$319,060
University of California, Irvine	Cancer

Determinants of Susceptibilty to Oxidixed Lipoproteins	1992 (Cycle 1)	$324,569
University of California, Los Angeles	Cardiovascular Disease

Tobacco Cessation Among Pregnant Low-Income Latino Women	1992 (Cycle 1)	$737,927
University of Southern California	Tobacco-Use Prevention and Cessation

Tobacco-Related Disease in Native California Twins	1992 (Cycle 1)	$634,515
University of Southern California	Epidemiology

Tobacco Carcinogen Transformation of Human Bronchial Cells	1992 (Cycle 1)	$621,592
University of Southern California	Cancer

Effect of Tobacco in Cervical Neoplasia in Young Women	1992 (Cycle 1)	$959,796
University of California, San Francisco	Epidemiology

Controlling Exposure to Environmental Tobacco Smoke	1992 (Cycle 1)	$205,357
University of California, Berkeley	General Biomedical Science

Cigarette Smoke, Nicotine & Acid-induced Duodenal Injury	1992 (Cycle 1)	$311,797
University of California, Los Angeles	General Biomedical Science

Vascular Response to Injury: Potentiation by Nicotine	1992 (Cycle 1)	$572,478
Stanford University	Cardiovascular Disease

Nicotinic Effects on Gene Expression in PC-12 Cells	1992 (Cycle 1)	$266,647
University of California, San Diego	Nicotine Dependence

Surveillance for Tobacco-Related Diseases	1992 (Cycle 1)	$627,384
Public Health Institute	Public Health, Public Policy, and Economics

Substrate Cycles, Calorigenesis & Smoking Cessation	1992 (Cycle 1)	$378,709
University of California, San Francisco	Public Health, Public Policy, and Economics

Prop 99 & Indigent Care: Lessons for Future Health Care Reform	1992 (Cycle 1)	$589,892
University of California, San Francisco	Public Health, Public Policy, and Economics

Novel Imuunotherapy for Small Cell Lung Carcinoma	1992 (Cycle 1)	$496,569
Childrens Hospital, Los Angeles	Cancer

Modifiers of Susceptibility to Smoking for Lung Cancer	1992 (Cycle 1)	$79,865
University of Southern California	Epidemiology

Effects of Prenatal Nicotine Exposure in Brain Development	1992 (Cycle 1)	$750,511
University of Southern California	General Biomedical Science

Nicotine Levels in Pregnant Women & Child Development	1992 (Cycle 1)	$335,068
University of California, Berkeley	Epidemiology

Management of Smoking by the Elderly in Long Term Care	1992 (Cycle 1)	$498,334
University of California, San Francisco	Public Health, Public Policy, and Economics

Gene Modification of Human Lung Tumor-Infiltrating Lymphocyte	1992 (Cycle 1)	$152,816
University of California, Los Angeles	Cancer

Nicotine Effects on Activity of Brain Catecholamine Neurons	1992 (Cycle 1)	$317,443
University of California, San Diego	Nicotine Dependence

Lung Cancer Associated Retinopathy	1992 (Cycle 1)	$352,945
University of California, Davis	Cancer

Role of Nicotine in Enodthelial Cell Function	1992 (Cycle 1)	$274,274
University of Southern California	Cardiovascular Disease

Molecular Mechanisms of Leukocyte Traffic to the Lungs	1992 (Cycle 1)	$345,676
Stanford University	Pulmonary Disease

Laboratory & Ambulatory Assessment of Smoking Withdrawal	1992 (Cycle 1)	$385,814
SRI International	Tobacco-Use Prevention and Cessation

Detrimental Influence of NO on Vascular/Platelet Functions	1992 (Cycle 1)	$288,188
University of California, Los Angeles	Cardiovascular Disease

Nicotine & Early Response Gene Expression in Brain	1992 (Cycle 1)	$99,290
University of California, San Francisco	Nicotine Dependence

Doses to Target Tissues from Inhaled Tobacco Smoke	1992 (Cycle 1)	$413,410
University of California, Irvine	General Biomedical Science

In Vitro Characterization of Human Airway Gland Cells	1992 (Cycle 1)	$511,793
University of California, San Francisco	Pulmonary Disease

Cost of Smoking in California	1992 (Cycle 1)	$185,697
University of California, San Francisco	Public Health, Public Policy, and Economics

Meta-Analysis of Prop 99 Competitive Grant Funded Projects	1992 (Cycle 1)	$232,993
University of California, Berkeley	Public Health, Public Policy, and Economics

Peptidyl Phosphonate Inhibitors to Human Leukocyte Elastase	1992 (Cycle 1)	$359,461
SRI International	General Biomedical Science

Pathogenesis of Cigarette Smoke-Induced Bronchitis	1992 (Cycle 1)	$487,719
University of California, Davis	Pulmonary Disease

Case study on tobacco use legislation	1992 (Cycle 1)	$160,907
RAND Corporation	Public Health, Public Policy, and Economics

Pulmonary Benzo(A)pyrene Metabolism & Tobacco Smoking	1992 (Cycle 1)	$303,996
University of California, Irvine	Pulmonary Disease

Novel Benzoxazinone Inhibitors to Hunam Leukocyte Elastase	1992 (Cycle 1)	$332,615
SRI International	General Biomedical Science

Nicotine, Hypertension & Induction of Aortic Disease	1992 (Cycle 1)	$182,010
University of California, Davis	Cardiovascular Disease

Experimental Approach to Tobacco Control for High-Risk Teens	1992 (Cycle 1)	$672,155
San Diego State University Research Foundation	Tobacco-Use Prevention and Cessation

Effects of Nicotine on Human Information Processing	1992 (Cycle 1)	$91,817
University of California, San Francisco	Public Health, Public Policy, and Economics

Benzo[A]pyrene: Biogenetic Effects on Hepatocytes in Vitro	1992 (Cycle 1)	$482,971
University of California, San Diego	General Biomedical Science

Control of Differentiation of the Early Embryonic Heart	1992 (Cycle 1)	$191,398
California Institute of Technology	Cardiovascular Disease

Oxygen Effects on Flow & function in Ischemic Myocardium	1992 (Cycle 1)	$278,044
University of California, San Francisco	Cardiovascular Disease

Effectiveness Ventilation & other Controls in Reducing ETS	1992 (Cycle 1)	$522,494
Public Health Foundation Enterprises, Inc.	General Biomedical Science

Studies of Proto-oncogenes & Growth Genes in Human Lung Cancer	1992 (Cycle 1)	$336,209
University of California, Los Angeles	Cancer

Analysis of the Effect of National Policies on Smoking Behavior	1992 (Cycle 1)	$579,489
University of California, San Diego	Public Health, Public Policy, and Economics

Thrombin Function/Inhibition in Tobacco-Related Diseases	1992 (Cycle 1)	$578,441
SRI International	Cardiovascular Disease

The Relationship of Tobacco Exposure to Semen Biomarkers	1992 (Cycle 1)	$186,739
University of California, San Francisco	Epidemiology

Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke	1992 (Cycle 1)	$313,201
Lawrence Berkeley National Laboratory	General Biomedical Science

Optical Partical Size Measurements of Tobacco Smoke	1992 (Cycle 1)	$103,468
University of California, Irvine	General Biomedical Science

Lung Cancer: p53 as a Paradigm of Tumor Suppression	1992 (Cycle 1)	$138,420
Cedars-Sinai Medical Center	Cancer

Phenols & PAH in Tobacco-Related Cardiovascular Disease	1992 (Cycle 1)	$421,763
University of Southern California	Cardiovascular Disease

Pulmonary Vascular Leukocytes & Tobacco Products	1992 (Cycle 1)	$435,721
University of California, Irvine	Pulmonary Disease

Regulation of the Nicotinic Receptors by Nicotine	1992 (Cycle 1)	$756,102
Salk Institute for Biological Studies	Nicotine Dependence

Cigarette Smoking & Facial Wrinkling	1992 (Cycle 1)	$515,796
University of California, San Francisco	Epidemiology

Cigarette Smoking & Sudden Cardiac Death	1992 (Cycle 1)	$783,629
University of California, San Francisco	Epidemiology

Neutrophil Cytostatic Activity Against Lung Tumor Cells	1992 (Cycle 1)	$223,628
University of California, Los Angeles	Cancer

Significance of Immune Complexes in Human Lung Carcinoma	1992 (Cycle 1)	$249,402
John Wayne Cancer Institute	Cancer

Tumor Infiltrating Lymphocytes & Pulmonary Macrophages	1992 (Cycle 1)	$423,786
University of California, Los Angeles	Cancer

Nicotine Enhanced Adrenal Medullary-Dependent Inflammation	1992 (Cycle 1)	$363,563
University of California, San Francisco	Nicotine Dependence

Smoking, Immunoglobulin E, & Cardiovascular Disease	1992 (Cycle 1)	$49,517
University of California, San Diego	Epidemiology

Assessing Tobacco Refusal Skills in Latino Youth	1992 (Cycle 1)	$584,719
San Diego State University Research Foundation	Public Health, Public Policy, and Economics

Vaccine Strategy Against Tumor-Associated Glycoproteins	1992 (Cycle 1)	$285,227
University of California, San Diego	Cancer

Cigarette Smoking, Steroidogenesis & Steroid Receptors	1992 (Cycle 1)	$316,942
Stanford University	General Biomedical Science

Genetic Aberrations in Tobacco-Related Lung Carcinogenesis	1992 (Cycle 1)	$214,126
University of Southern California	Cancer

Filipino Smoking Prevalance Survey in California	1992 (Cycle 1)	$153,533
Asian & Pacific Islander American Health Forum	Epidemiology

Pregnant Smokers: Predictors of Cessation & Relapse	1992 (Cycle 1)	$451,831
University of California, San Francisco	Tobacco-Use Prevention and Cessation

Precursors & Correlates of Smoking in Adolescents	1992 (Cycle 1)	$63,786
Molecular Medicine Research Institute	Epidemiology

Effects of Smoking on High Density Lipoprotein Species	1992 (Cycle 1)	$203,942
University of California, San Francisco	Cardiovascular Disease

Monoclonal Antibody-Drug Conjugate Treatment of Lung Cancer	1992 (Cycle 1)	$258,750
Scripps Clinic & Research Foundation	Cancer

Modulatory Effects of Tobacco Products in Immune Function	1992 (Cycle 1)	$85,387
University of California, San Diego	General Biomedical Science

Tobacco Smoke: Mechanistic Roles in COPD	1992 (Cycle 1)	$250,297
University of California, Davis	Pulmonary Disease

The Role of Sleep in Successful Smoking Cessation	1992 (Cycle 1)	$180,399
Long Beach Research Foundation	Tobacco-Use Prevention and Cessation

Tobacco Smoke, Free Radicals, Antioxidants & Disease	1992 (Cycle 1)	$215,713
University of California, Berkeley	Pulmonary Disease

Self Management for Tobacco-Related Chronic Diseases	1992 (Cycle 1)	$1,049,257
Stanford University	Public Health, Public Policy, and Economics

Mechanism of Endothelin-Stimulated ANF Secretion	1992 (Cycle 1)	$447,480
San Diego State University Research Foundation	Cardiovascular Disease

Effects of Smoke on Fluid Transport Across Trachea	1992 (Cycle 1)	$395,115
University of California, Berkeley	Pulmonary Disease

Physician Incentives & Smoking Cessation Effectiveness	1992 (Cycle 1)	$745,316
University of Southern California	Tobacco-Use Prevention and Cessation

The Economic Effects of California Cigarette Taxation	1992 (Cycle 1)	$474,976
University of California, Berkeley	Public Health, Public Policy, and Economics

Characterization of Particulate-Phase ETS in Differing Environments	1992 (Cycle 1)	$454,509
Lawrence Berkeley National Laboratory	General Biomedical Science

Predictors of Weight Gain After Smoking Cessation	1992 (Cycle 1)	$809,412
Kaiser Foundation Research Institute	Tobacco-Use Prevention and Cessation

Comparison of Nicotine Metabolism in four Ethnic Groups	1992 (Cycle 1)	$449,327
University of California, San Francisco	Public Health, Public Policy, and Economics

Effects of Passive Smoking on Experimental Atherosclerosis	1992 (Cycle 1)	$340,594
University of California, San Francisco	Cardiovascular Disease

---